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INTRODUCTION 
             The word pain is derived from greek word poena,  meaning 
penalty .It is defined as an unpleasant sensory or emotional experience 
associated with actual or potential damage  or described in terms of 
such damage 
 But this definition is critiqued because nonverbal or preverbal 
individuals and those who are cognitively impaired may be unable to 
describe their pain.
1
  
Early assumptions that neonate and young children are less able 
to respond to pain and stress has been refuted and stress response in 
particular has been well characterized. The developmental 
neurobiology of pain is complex and changes in pain processing takes 
place in early life. 
Mechanism of acute pain includes both peripheral and central 
components of the response to noxious stimulation of injury. In the 
periphery ,injury induces a local inflammatory response which 
includes sensitization of nociceptors and primary hyperalgesia .High 
threshold A and C fibres conduct noxious inputs to CNS, initiating a 
chain of events which includes reflex withdrawl from the stimulus, 
aversive behaviour, and perception of pain. Sustained ‘C’ fibre inputs 
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provoke a number of changes, known as central sensitization, which 
alter spinal sensory processing, leading to hyperalgesia and allodynia 
at the site of injury. 
These mechanisms are different in early life. 
1. Clear measurable responses to pain which can be reduced by 
analgesia have been observed at all ages including the newborn 
but these are important differences in these responses. Sensory 
thresholds are lower in neonate and reflex response more 
exaggerated. The motor component of the withdrawl reflex is 
less coordinated and tends to involve whole body movements. 
In addition, the receptive fields of sensory neurons are relatively 
larger and more overlapping than in adults which probably 
influences sensory discrimination and localization. 
2. Evidence for nerve plasticity and “windup” or sensitization after 
prolonged painful stimulation also exists at all ages. In adults, 
CNS stimulation following noxious occur as a result of 
sustained C fibre inputs. Both  A delta fibre and C fibres rather 
than C fibres the number, mediated in early life. 
3. The number, location distribution and functionality of many 
important receptors and N methyl D aspartate(NMDA) receptor, 
which is important for central sensitization. 
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4. The peripheral inflammatory response is not fully matured at 
birth and also undergoes developmental regulation. 
Pain measurement
2,3,4
 
The vast range of physiological and behavioural responses, 
cognitive abilities, psychological development between the preterm 
neonate and adolescent poses enormous problems for valid and 
reliable pain measurement. 
Methods of pain assessment 
1) Self report measures: faces, Manchester, VAS pain scales 
2) Observational behavioural measures: e.g., CHEOPS, FLACC. 
COMFORT SCALE 
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FLACC behavioural pain scale: total score0_10 
criiteria Score 0 Score 1 Score 2 
Face No particular 
expression or 
smile 
Occasional grimace or 
frown, withdrawn, 
uninterested 
Frequent to 
constant 
quivering chin, 
clenched jaw 
Legs Normal position 
or relaxed 
Uneasy, restless, tense Kicking, or legs 
drawn up 
Activity Lying quietly, 
normal position, 
moves easily 
Squirming, shifting 
back and forth, tense 
Arched, rigid or 
jerking 
Cry No cry (awake 
or asleep) 
Moans or whimpers; 
occasional complaint 
Crying steadily, 
screams or sobs, 
frequent 
complaints 
Consolability Content, 
relaxed 
Reassured by 
occasional touching, 
hugging or being 
talked to, distractible 
Difficult to 
console or 
comfort 
5 
 
             Given the complexity of the pain mechanism, effective 
treatment of pain requires the use of multimodal therapies that target 
multiple sites along pain pathways. 
Pain can be treated at the peripheral level using local 
anaesthetics, NSAIDs
5,6 
,or opioids. At the spinal cord level it can be 
treated with local anaesthetics, opioids. At the spinal cord level it can 
be treated with local anaesthetics, opioids, alpha 2 agonists, and 
cortical level opioids can be used. Most cases of moderate to severe 
pain are best treated with a combination of analgesic techniques 
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AIM OF STUDY 
 
This study compares the efficacy and safety of using caudal 
epidural administration of dexmedetomidine 1 µg/kg with  0.25% 
bupivacaine vs 0.25% bupivacaine  for providing postoperative pain 
relief in children undergoing lower abdominal surgeries. 
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ANATOMY OF CAUDAL SPACE
7,8,9
 
 
Caudal anaesthesia is the oldest and still the most commonly 
used technique of epidural blockade in children. It is performed via the 
sacral hiatus, through the sacrococcygeal membrane. Posterior 
superior iliac spines and sacral hiatus forms equilateral triangle.  
                        
 
 
It is a V-shaped aperture resulting from the lack of dorsal fusion 
of fourth and fifth sacral vertebral arches. It is limited laterally by two 
palpable bony structures, the sacral   cornua and it is covered by 
sacrococcygeal membrane (sacral continuation of ligamentum flava). 
The distance from skin to epidural space hardly influenced by age and 
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weight of the patient, 25 mm long needles are long enough to reach 
the sacral epidural space and short enough to prevent inadvertent dural 
puncture in most patients. With growth, the axis of sacrum changes 
and sacral hiatus may even close. These changes make the caudal 
epidural anaesthesia more difficult to perform in children older than 6 
to7 years of age 
Technique of caudal block
10
 
As in the preparation for any major regional anaesthesia 
technique, all equipment must be assembled, checked, including block 
tray, resuscitation equipment and suction. 
 
The needle used for this procedure will depend on clinical 
circumstances. For single injection caudal block in a child, 2-3 cm 
disposable 23 to 25 G needle should be used. The needles should be 
9 
 
short bevelled because they give better feel when different tissues are 
penetrated and they have lesser tendency to form barbs if bone is 
struck. The bevel is more likely to enter the canal if it is very shallow. 
If catheter is planned  a short 5 to 7 cm  18G Crawford tip needle and 
standard epidural catheter is recommended. 
The use of tuohy needle to insert a catheter is not 
recommended. The needle tip will lie in the long axis of the canal, and 
Tuohy tip there will direct the catheter toward the wall rather than the 
axis of the canal, as with a Crawford or IV needle. 
Positioning:
10
  
 
1. The preferred position is lateral sim’s position. Left side down 
for right handed person with the lower leg slightly flexed at the 
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hip and upper leg more flexed such that it lies over and above 
the lower leg and also in contact with bed .This manoeuvre 
tends to separate the buttocks. 
2. Prone position with pillow under the pelvis. Both legs are 
rotated so that the toes of both feet are facing medially. This 
again separates the  buttocks 
3. Knee chest position still may be useful, particularly for pregnant 
patients. 
 
Confirmation of bony landmarks is the key to successful block. In 
the thin young patients protrusions of sacral cornua can be seen 
without palpation, and the shallow depression over the sacral hiatus 
can be seen between them. 
Having found the area of suspected hiatus, it is well to keep the 
palpating hand in position until after the needle insertion because 
landmarks can be easily obscured especially in obese patients. 
Because the canal has tendency to become deeper as one progresses 
cephalad, the canal entry is facilitated if a point of needle is chosen 
toward the upper end of hiatus. The intial angle of needle insertion is 
120
0
 to the back. Penetration of sacrococcygeal ligament has a 
characteristic feel to it. This ‘pop’ can be learned only by practice. 
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There is feeling of emptiness after penetration of ligament in most 
cases until the anterior wall is contacted. This contact should not be 
sought. The needle, both hub and shank should then be depressed 
toward the skin to align the needle approximately in the long axis of 
the canal. It may then be inserted further a centimeter. After aspiration 
,a test dose of local anaesthetic drug is  injected  at this point. 
 
SIGNS OF CORRECT NEEDLE PLACEMENT
10 
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 The presence of sacral bone on each side does not 
exclude the possibility of entry into a decoy hiatus. 
 The lack of CSF, air, blood on aspiration is important. 
 There should be no  subcutaneous bulge or superficial 
crepitus after injection of 2 to 3 ml of anaesthetic solution 
or air 
 There should be no tissue resistance to injection 
 When correctly positioned needle should be able to move 
in the canal 
 There should be no local pain during injection 
 Paresthesia or feeling of fullness that extends from 
sacrum to the soles of the feet is common during injection 
but ceases on completion. 
 A useful test when substantial doubts about the  needle 
position cannot be resolved is to inject 2 to 4 ml of air 
while listening with ear or stethoscope over lumbar 
vertebra 
 If catheter is inserted ,it should enter the canal freely with 
same or greater ease than in lumbar region 
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COMPLICATIONS 
 Epidural haematoma 
 Epidural abscess 
 Dural puncture 
 Intravenous placement 
 Intraosseous  placement  
 
POSTOPERATIVE PROBLEMS 
 Periosteal hematoma and pain. 
 Urinary retention  
 Infection 
 Neurological complications 
Indications and contraindications: 
Caudal epidural anaesthesia is indicated for infra-umbilical 
surgical procedures, including inguinal hernia repair, urinary and 
lower digestive tract surgery, and orthopaedic procedures on pelvic 
girdle and lower extremities. 
Contraindicated in major malformations of sacrum , meningitis 
and intracranial hypertension.  
14 
 
Selection of drug   
The drug dose required for epidural blockade at a given 
dermatomal level depends on the volume (not concentration) of the 
local anaesthetic and the volume of epidural space, which may 
change with age. The formula of takasaki and colleagues has best 
approximated good clinical result is Volume (ml)=0.05mlkg 
/dermatome to be blocked 
         
Caudal epidural anaesthesia is basically a single shot technique. 
The dosage of armitage
11 
remains the most dependable.  
 0.5 ml /kg all sacral dermatomes are blocked, 
1ml/kg sacral and lumbar dermatomes are blocked, 
At 1.25 ml/kg there is a danger of excessive rostral spread 
(aboveT4)
12
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PHARMACOLOGY OF BUPIVACAINE
13
 
Bupivacaine is an amide local anaesthetic agent.  It belongs to 
the homologous series of n-alkyl substituted pipecholyl xylidines.  It 
was first synthesized by Ekenstam in 1957 and was used clinically in 
1963.  It is produced for clinical use as a racemic mixture containing 
both ‘S’ and ‘R’ forms in equal proportion.  It is supplied as a 
hydrochloride salt. 
 
CHEMICAL STRUCTURE: 
 
 1-butyl-n-(2,6-dimethyl phenyl) -2-piperidine decarboxamide 
hydrochloride monohydrate.   
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PHYSIO-CHEMICAL PROFILE
11
: 
 Molecular weight   -  288 
 pKa     - 8.1 
 Plasma protein binding  -  95% 
 Partition coefficient  - 28 (lipid solubility) 
 T ½     - 210 min 
 Clearance    - 8.3 l/min 
 
MECHANISM OF ACTION: 
Like all the other local anaesthetics, it inhibits Na channels.  It 
decreases or prevents large transient increase in permeability of the 
cell membranes to Na ions that follows depolarization of the 
membrane and thereby blocks the nerve conduction.  It also reduces 
the permeability of the resting nerve membrane to potassium ions as 
well as sodium ions and hence has got a stabilising action on all 
excitable membranes. 
 
 
17 
 
EFFECTS: 
  Local – nerve blockade 
 Regional – pain, temperature, touch, motor power and 
vasomotor tone supplied by the nerves are blocked. 
 Systemic – effects due to systemic absorption or accidental 
intravenous administration. 
It is 4 times more potent than lignocaine but the onset of action 
is slower.  The duration of action is longer.  Sensory block is 
more marked than the motor block. 
 
SYSTEMIC EFFECTS: 
CNS: 
 Can produce 
 Circumoral numbness, metallic taste 
 Tinnitus, light headedness, dizziness 
 Confusion, slurred speech 
 convulsions 
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CVS: 
 depresses automaticity and contractility of the heart 
 slows conduction of cardiac action potential as  it causes 
prolongation of PR and QR intervals on ECG. 
 Re-entrant phenomenon and ventricular arrhythmias 
 Results mostly from high lipid solubility 
 R-enantiomer is more toxic than S-enantiomer 
 Pregnancy increases cardiotoxic effects of bupivacaine 
KINETICS: 
 Rapidly absorbed from the site of injection 
 Peak systemic concentration – 5 to 30 minutes after 
administration 
 Duration of action – 360 to 720 minutes 
 Metabolism in liver – dealkylation to pipecoloxylidine, 
aromatic hydroxylation 
 Excretion – 5% by kidney as unchanged drug and rest as 
metabolites 
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PREPARATION: 
 0.25%, 0.5% solutions in 10, 20 ml vials, respectively 
 5mg/ml (0.5%) bupivacaine with 80 mg dextrose (to increase 
baricity) in 4 ml ampoules for subarachnoid injection 
(baricity – 1.0207) 
USES: 
 Central neuraxial blocks 
 For local infiltration subcutaneously 
 Peripheral nerve blockade 
CONTRAINDICATIONS: 
 Known hypersensitivity to amide local anaesthetics 
 Intravenous regional anaesthesia(IVRA) 
MAXIMAL DOSE: 
 2.5 mg/kg body weight and the strength used is 0.25 – 0.75% 
with or without adrenaline (1:200000 or 1:400000)
11
.  Adrenaline does 
not prolong its effect, but reduces its toxicity 
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PHARMACOLOGY OF DEXMEDETOMIDINE14 
 
 
Dexmedetomidine is the d-enanatiomer of medetomidine which 
was a drug initially used in veterinary medicine for sedation and 
analgesia. It was introduced into clinical practice in 1999 and was 
approved by FDA for sedation of mechanically ventilated patients for 
less than 24 hours 
It belongs to the imidazole subclass of α2 receptor agonists, 
similar to clonidine. α2 agonists provide sedation, anxiolysis, 
analgesia, hypnosis and centrally mediated sympatholysis. The initial 
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idea behind the use of dexmedetomidine was due to observations 
made in patients receiving clonidine therapy. 
Clonidine therapy has been found to decrease the MAC value of 
halothane when used along with dexmedetomidine. 
Dexmedetomidine is a very selective α2 agonist with a high 
ratio of specificity for α2 when compared to α1(1600>1), when 
compared to clonidine (200>1). 
METABOLISM AND PHARMACOKINETICS  
After administration, dexmedetomidine is rapidly redistributed 
and is extensively metabolised in the liver by undergoing conjugation, 
n-methylation or hydroxylation and is excreted in the urine and faeces. 
Dexmedetomidine is largely protein bound (94%). Since 
dexmedetomidine has such profound effects on the cardiovascular 
system, large doses may alter its own pharmacokinetics. With large 
doses, due to marked vasoconstriction, the drug’s volume of 
distribution is decreased. The drug displays non linear 
pharmacokinetics. These pharmacokinetics are unaltered by age, 
weight or renal failure, but it is a function of height. 
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The elimination half life is 2-3hours with a context sensitive 
half time of 4 minutes after a 10 minute infusion to 250 minutes after 
an 8 hour infusion. 
PHARMACOLOGY 
It is a nonselective α2 agonist. Three subtypes of α2 receptors 
have been described in humans α2a, α2b and α2c. The α2a receptors 
are located in the periphery and the α2b and α2c receptors are located 
in the brain and spinal cord. These receptors are membrane spanning 
G proteins and stimulation causes inhibition of adenylate cyclase and 
modulation of ion channels. 
Post synaptic α2 receptors cause vasoconstriction, whereas 
presynaptic α2 receptors inhibit the release of norepinephrine and 
attenuate the effect of vasoconstriction. The overall effects of 
stimulation of α2 receptors causes  sedation and analgesia, 
sympatholysis. 
Stimulation of α2a receptors- 
 Presynaptic inhibition of norepinephrine release 
 Analgesia  
 Sedation  
 Hypotension  
23 
 
 Inhibition of epileptic seizures 
 
Stimulation of α2b receptors- 
 Hypertension 
 Placental angiogenesis 
 Hypertensive effect of etomidate 
 Analgesic effect of nitrous oxide 
Stimulation of α2c receptors- 
 Feedback inhibition of adrenal catecholamine release 
 Analgesic effect of moxonidine 
 Modulation of behaviour 
EFFECTS ON CNS 
SEDATION 
They produce a sedative hypnotic effect by action on the locus 
coeruleus and an analgesic effect by action on the locus coeruleus and 
the spinal cord. It produces a decrease in the activity of the projections 
of locus coeruleus to the ventrolateral preoptic nucleus. This increases 
GABA and galanin release in the tuberomammillary nucleus which 
then produces a decrease in histamine release  in the cortical and 
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subcortical projections. These agonists inhibit ion conductance 
through L type or P type calcium channels and facilitates conductance 
through calcium activated potassium channels. 
Patients sedated with dexmedetomidine are easily arousable and 
will usually follow commands and cooperate even while being 
tracheally intubated. If left undisturbed, these patients fall asleep 
easily. The sleep induced by dexmedetomine is very similar to 
physiological non-rapid eye movement (NREM)sleep. There is limited 
respiratory depression and this drug provides a wide safety margin. 
Since it is approved for use only for short term sedation(less 
than 24 hour), chances of addiction, dependence or tolerance does not 
seem to be a problem 
Other uses of dexmedetomidine include- 
 Addiction treatment 
 Use in rapid detoxification of opioid 
 Cocaine withdrawal syndrome 
 Iatrogenically induced Benzodiazepine  and opioid tolerance 
after prolonged sedation 
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ANALGESIA 
α2 agonists have an analgesic effect when injected in the 
intrathecal or epidural route. When injected intrathecally they help 
with cancer pain, neuropathic pain and other kinds of short term pain. 
When dexmedetomidine  is injected into the epidural space it rapidly 
diffuses into the intrathecal space, studies showed that 22% of the 
drug was found in the CSF. A fall in the blood pressure is seen within 
5-20 minutes of administration. The primary site of analgesic action is 
deemed to be the spinal cord. 
Intrathecal or epidural administration of dexmedetomidine 
decreases the narcotic requirements by 50%. 
Dexmedetomine has not been found to be useful in attenuating 
heat pain or electrical pain. The analgesic effect of dexmedetomine 
has been compared to remifentanil. Therefore when used in a clinical 
situation where pain is likely to occur, it is efficacious to use 
dexmedetomine in addition to a narcotic agent. 
OTHER CNS EFFECTS 
Dexmedetomine reduces intracerebral catecholamine outflow 
and thus results in less neural damage following injury. It modulates 
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apoptotic and anti apoptotic proteins and decreases the release of the 
excitatory neurotransmitter glutamate. 
Dexmedetomine also reduces muscle rigidity after high dose 
opioid administration. It also increases growth hormone secretion in a 
dose dependent manner but does not affect the other pituitary 
hormones. 
RESPIRATORY SYSTEM EFFECTS 
Dexmedetomine administered in concentrations for sedation 
reduces minute ventilation, but the response to increasing 
carbondioxide is retained. At the highest concentrations, Paco2 
increased by 20% and respiratory rate increased with increasing 
concentrations from 14 breaths/min to 25 breaths/min. 
Dexmedetomine also has hypercarbic arousal phenomenon which has 
been described during normal sleep as a protective phenomenon. 
CARDIOVASCULAR SYSTEM EFFECTS 
It causes a decreased heart rate, decreased systemic vascular 
resistance; indirectly decreases myocardial contractility,cardiac output 
and systemic blood pressure. A bolus dose of dexmedetomine usually 
causes a biphasic response .  An initial increase in blood pressure and 
a decrease in heart rate occurs from the baseline which is probably due 
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to the vasoconstrictive effects when stimulating α2 receptors. Heart 
rate returned to baseline  and blood pressure gradually declined to 
15% below baseline by one hour. 
It causes a compensated reduction in systemic sympathetic tone 
without changes in baroreflex sensitivity. It also blunts the heart rate 
and systemic sympathetic activation owing to sweating. 
The perioperative use of α2 agonists reduces the incidence of 
perioperative myocardial ischaemia. 
USES 
As a pre medicant was 0.33 to 0.67ug/kg given 15 minutes before 
surgery. It reduces thiopental requirements by 30% and decreases the 
volatile requirement by 25% and attenuates the haemodynamic 
response to endotracheal intubation when compared with 2ug/kg of 
fentanyl. 
It can be used for maintenance of anaesthesia  with propofol or 
desflurane plus dexmedetomidine wtih a 0.5-0.8ug/kg bolus and a 
0.4ug/kg/hr infusion. It improves haemodynamics compared with 
desflurane-fentanyl or propofol-fentanyl anaesthetics. 
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It is used a sedative at a dose of  0.2 to 0.7ug/kg/hr. It has also been 
used a sedative for patients with narcotic induced respiratory 
depression or sleep apnoea 
 
ALPHA 2 ANTAGONIST: 
Atipamezole: 
                       Scheinin et al. reported about the ability of atipamezole, 
a novel selective α2-adrenoceptor antagonist, to reverse the sedative 
properties of  of intramuscular dexmedetomidine were  dose-
dependently antagonized by intravenous atipamezole.  However, the 
sensitivity for reversal of these two responses may be different. 
Because the agonist and the antagonist have similar elimination half-
lives, the likelihood of recurrence of the clinical effects of 
dexmedetomidine after reversal by atipamezole is small. Therefore the 
a2 agonists provide a titratable form of hypnotic sedation that can be 
reversed  readily. 
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REVIEW OF LITERATURE 
 
Hennawy et al, 2007
15
 
They did a study on 60 patients undergoing vesicourethral reflux 
surgery allocated into three group as A,B, C. After induction of 
general anaesthesia with oxygen and sevoflurane and, intubation was 
done. After putting patient in lateral position group A received 1ml /kg 
of caudal bupivacaine 0.25% with dexmedetomidine 2µ/kg making 
volume of 1ml,group B received 1ml /kg of 0.25%bupivacaine and 
clonidine 2µ/kg making volume of 1ml, group C received caudal 
bupivacaine 0.25% with 1ml of normal saline. Premedication like 
atropine was not given in this study. No other sedatives. Analgesics, 
antiemetics was given intra operatively. End tidal sevoflurane 
concentraton, analgesia time, FLACC score, sedation score was 
monitored for first 24 hours. Hypotension requiring IV fluid boluses 
and bradycardia needed atropine also noted perioperatively. Duration 
of analgesia in group A was 16 hours with confidence interval of 
95%,in group B analgesic time was 12hours, in group C analgesic 
time was 5 hours(p value<0.001). All group of patients experienced no 
significant haemodynamic changes. No significant difference was 
noted between clonidine and dexmedetomine regarding analgesic 
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time. Morphine 0.1mg/kg was given as rescue analgesia if  FLACC 
score more than 4. 
 
Vijay G anand et al.,
16
 
They compared the effect of adding dexmedetomine to caudal 
ropivacaine for postoperative analgesia in chidren undergoing lower 
abdominal surgeries in children. They selected 60 paediatric patients 
undergoing lower abdominal surgeries and allocated into two 
groups.group R received 1ml /kg of 0.25% ropivacaine with 0.5 ml of 
normal saline group RD received 1 ml/kg of 0.25% ropivacaine with 1 
microgram/kg of dexmedetomidine making volume to 0.5ml after 
induction of general anaesthesia by 50%:50% oxygen and nitrous 
oxide with sevoflurane 8% in spontaneous ventilation. Duration of 
analgesia was assessed by FLACC score, sedation by ramsay sedation 
score, emergence time from anaesthesia was noticed. Intra operatively 
HR, NIBP, SPO2 was monitored every 5 minutes then postoperatively 
for every 4 hours. Bradycardia was considered HR 80/min in children 
less than 1 year, less than 60/min between 1 to 6 years. Hypotension 
was defined systolic blood pressure 70 plus (2x age in years) with 
altered tissue perfusion. Duration of analgesia was 5.5 in group R 
compared to 14.5 hours  in group RD .Sedation score  also more in 
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group RD. No significant hemodynamic changes occurs in introp and 
postoperatively. Adverse effects like bradycardia, hypotension, 
urinary retention, PONV, respiratory depression (SPO2 less than 95%) 
also statistically not significant in between these two groups. 
Syp.Paracetamol 15mg /kg was given as rescue analgesic if FLACC 
SCORE more than 4. 
 
Saadawy et al.,
17
 
It was the first study to compare the effect of adding dexmedetomine 
to caudal bupivacaine for postoperative analgesia in children between 
the ages of 1to 6 years undergoing infraumbilical surgeries. It was 
prospective, randomised, double blinded study. 60 patients randomly 
allocated into two groups (n=30). Patients are induced with Inj, 
Propofol 3-4 mg/kg and appropriate size LMA was inserted. BIS, 
NIBP, HR, SPO2, ETCO2 was monitored intra operatively. BIS was 
maintained around40-60 during intraop period by adjusting 
sevoflurane concentration. Inadequate analgesia was considered 
increase in HR, BP more than 15% from baseline value. Hypotension 
and bradycardia was defined decrease in HR, BP more than 30% from 
baseline values. dexmedetomine group received 1µ/kg with 
bupivacaine 0.25% 1ml/kg, bupivacaine group received iml/kg of 
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0.25% bupivacaine. Sedation score, objective pain scale, emergence 
score was noted postoperatively. Mean duration of sedation in 
dexmedetomine group was 210±72mins compared to bupivacaine 
group 24±72mins (p value<0.05). Maximal decrease in BP was noted 
between 25-30 minutes in dexmedetomidine group. Maximal decrease 
in HR was31±5 in group B compared to38±8 in  group BD. maximal 
decrease in HR was noted in 39±7 mins in group BD compared 
to28±7 minutes in group B. One patient went for bradycardia required 
atropine. Hypopotension was treated with vasopressors or fluid 
boluses. They conclude that caudal dexmedetomidine provide 
prolonged analgesia with arousable sedation. 
 
Mausumi neogi et al.,2010., 
They conducted randomised, control,double blinded study on  75 
patients undergoing elective inguinal herniotomy allocated into rhree 
groups. All patients received oral midazolam 0.5 mg/kg  as 
premedicant 30 minutes before surgery. Anaesthesia was induced with 
oxygen with incremental concentration of halothane. Entotracheal 
intubation was after paralysing patient with 0.5mg /kg of 
Inj.atacurium. Anaesthesia was maintained with oxygen and nitrous 
oxide 40%:60% with 0.5%halothane. NIBP, HR, SPO2 was monitored 
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intra operative and postoperative period. Duration of analgesia was 
assessed by CRIES scale. Analgesic time in group R was6.32 ± 
0.46hours (median, confidence interval 95%), group C was 13.17 ± 
0.68 hours, group D was15.26±0.86hours. Sedation score in first hour 
in all three group was maximum of 2, in six hours it was 3, in 12 hours 
it was 4 according to 4 point scale.no significant haemodynamic 
difference was noted in all three groups in first 24 hours.adverse 
effects like respiratory depression, bradycardia, hypotension, pruritus, 
post operative nausea and vomiting also statiscally not significant in 
all 3 groups. 
 
Xiang Q et al.,2012 november
18
 
They conducted a study on sixty patients undergoing hernia sac 
ligation assigned into two groups for addition of dexmedetomine to 
caudal bupivacaine for inhibing tractional pain. All patients 
premedicated with oral midalazolam 0.5mg/kg one hour prior to 
surgery. Anaesthesia was induced with ketamine intravenous 
injection. Standard monitoring like SPO2. HR, NIBP was used. 
Traction pain was considered if increase in HR, NIBP more than 20% 
from baseline value. Ketamine rescue analgesia was given if patient 
feels pain. Post operatively Inj. Fentanyl was given as rescue 
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analgesia.  In group B they received 0.25% bupivacaine 1ml/kg, in 
group BD they received 0.25% bupivacaine 1ml/kg with 1µ/kg 
dexmedetomine. First fentanyl injection was given after 860 minutes 
in group BD compared to 320 minutes in group B. Amount of fentanyl 
injection needed in group BD was 2.5µ(1.2)  compard to 6.9µ(1.6). 
They concluded that group BD needed lesser doses of fentanyl 
compared to group B. In BD group one patient needed ketamine 
rescue analgesia compared to 13 patients needed IV ketamine rescue 
analgesia in group B. 
 
Mostafa el hamamsy et al.,
19
 
They conducted a study on 112 patients undergoing surgical procedure 
lasting more than 90 minutes to test the efficacy of adding additives to 
single shot caudal to prolong postop analgesia and reduce the dose of 
rescue analgesia. They received1ml /kg of equal mixture of 
0.25%bupivacaine and lignocaine 1% with dexmedetomine 1.5µ/kg in 
group D, 1ml/kg of local anaesthetic mixtures with clonidine 2µ/kg in 
group C,1ml/kg of local anaesthetic tramadol 2µ/kg in group T,1ml/kg 
of local anaesthetic with fentanyl 2µ/kg in group F after induction of 
general anaesthesia with halothane and oxygen with 60%nitrous 
oxide. Anaesthesia was maintained isoflurane 0.6% with oxygen and 
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nitrous oxide. The study was conducted was conducted in ASA I –II 
patients weighing 10-30kg, between 3 to 10 years of age. 12 patients 
were excluded from study because of surgical procedure lasting less 
than 90 minutes and failed caudal. HR, BP, SPO2 was monitored for 
first 6 hours. Inadequate analgesia was considered increase in HR or 
BP more than 15% from baseline. Hypotension and bradycardia was 
defined if HR or BP decreaing more than 20% from baseline. Pain was 
assessed by objective pain scale, if more than 11 rectal paracetamol 
15mg/kg was given. Sedation score was assessed by subjective 
sedation scale. They concluded mean duration of analgesia in group B 
was 245±10 mins,in group D 347±10 minutes. In group C 350±10 
mins, in group T 280 mins, in group F 280 minutes. Clonidine and 
dexmedetomine group provide significant postoperative analgesia than 
tramadol and fentanyl group. But clonidine and dexmedetomine group 
there is no statiscally significant postoperative duration of analgesia.7 
patients in clonidine group 5 patients in dexmedetomineetomine group 
required atropine to bradycardia. It was statiscally significant. 
 
Rajni Gupta et al 
20
, compared intrathecal dexmedetomidine and 
fentanyl as adjuvants to Bupivacaine in 60 patients undergoing lower 
abdominal surgeries, they were allocated into 2 groups and received 
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either 12.5mg hyperbaric bupivacaine + 5µg dexmedetomidine (group 
D) .   12.5 mg Hyperbaric bupivacaine + 25µg of fentanyl (group F) . 
They observed that patient in group D had longer sensory and motor 
blockade and reduced demand for rescue analgesia for 24 hours. 
 
Sukwinder Kaur Bajua et al,
21
 did a comparative evaluation of 
epidural dexmedetomidine and clonidine in patients undergoing 
vaginal hysterectomies.50 patients undergoing vaginal hsytrectomies 
were randomly allocated in 2 groups : RD   and RC. 
RD -  Ropivacaine (17 ml of 0.75%) + dexmedetomidine(1.5 µg/kg) 
RC-  Ropivacaine (17 ml of 0.75%) +  Clonidine (2 µg/kg) 
Onset of analgesia, sensory and motor blockade, sedation level , 
duration of analgesia and  adverse effects were compared. 
Demographic profile, initial and post operative block variables and 
cardio pulmonary parameters were comparable non significant in both 
groups. whereas sedation was better in RD group and incidence of side 
effects was less in RD group. 
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Ansermino et al.,
22
 
They conducted study for evaluating the efficacy of adding non opioid 
drugs like clonidine, midazolam, ketamine to local anaesthetics for 
prolonged duration of analgesia. Also they concluded that non opioid 
drugs effectively prolongs duration of analgesia. However 
neurotoxicity of the drugs cannot be excluded. 
 
Parmeswari et al.,
23 
They conducted a prospective, randomized control study on 100 
children aged 1 to 3 years posted for infra umbilical surgeries for 
testing the efficacy of α agonist like  clonidine to bupivacaine forpost 
operative analgesia in children. 
Group A received one ml per kg of 0.25% buoivacaine . 
Group B received one ml per kg of caudal dexmedetominine and 
1µ/kg of clonidine  analgic quality was assessed by FLACC score, it 
was 593 minutes in clonidine group compared to bupivacaine group 
alone. 
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Isik B et al.,
24
 
They did a randomised, double blinded study on children undergoing 
MRI procedures by administration of intravenous dexmedetomine 
1µ/kg reduces emergence agitation after sevoflurane anaesthesia. 
Anaesthesia was induced with sevoflurane 8% with O2:N2O 50:50% 
and maintained with sevoflurane 1.5%. One group received 
dexmedetomidine after induction of anaesthesia, other group does not 
receive any medication. SPO2, NIBP, HR was monitored every 5 
minutes during procedures. Agitation score was assessed by 5 point 
scale. The agitation score of ≥4 for≥5 was considered delirium.mean 
agitation score in dexmedetomidine was significantly lower than 
placebo group. 
 
Hansen TG et al.,
25
 
They compared the effect of adding intravenous and caudal clonidine 
to caudal bupivacaine for post operative analgesia after hypospadiasis 
repair surgery. 46 children were randomly devided into two groups. 
One group received caudal clonidine 2µ/kg with 0.5ml of 
0.25%bupivacaine. Other group received 2µ/kg clonidine intravenous 
injection with 0.5ml /kg of 0.25% bupivacaine group. Sedation score, 
motor block, require of rescue analgesia morphine was assessed. They 
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concluded that intravenous or caudal route has same duration of 
postoperative analgesia. It was statiscally not significant.  
 
Ashraf Abdul Baki Abdul Baset .M.D et al,
26
 
They conducted a study to evaluate the analgesic properties of 
dexmedetomidine alone or in combination with bupivacaine 0.125% 
when administered as
 
an epidural infusion for the treatment of 
postoperative pain
 
in patients undergoing extensive abdominal 
surgery.
 
 Ninety adult patients scheduled for abdominal surgery were 
studied. An epidural catheter was inserted in all patients at the T8-T9 
vertebral interspace and a 15 ml of 0.5% bupivacaine injected 
epidurally. General anaesthesia was induced with propofol and 
atracurium and was maintained with a sevoflurane. VAS was used for 
assessment of postoperative pain and when it reaches 30, patients were 
then randomly divided into three groups to receive an epidural 
infusion at 10 mL/h of bupivacaine 0.125%, dexmedetomidine 0.5 
µg/kg/hr in bupivacaine
 
0.125% and dexmedetomidine 0.5 µg/kg/hr 
diluted in 0.9% saline in Group B, Group DB, and Group D, 
respectively. VAS score, sedation score, sensory and motor blockade, 
MAP and HR were monitored and recorded. Rescue analgesia was 
given in the form of patient controlled analgesia and the total 
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morphine requirements were recorded together with the time to first 
analgesic requirement. The  Group DB having the lowest
 
morphine
 
requirements (11.9 ± 15.6 mg) and the longest interval before 
analgesia was requested (12.0 ± 6.5 hr) while Group B, had the 
shortest period (4.0 ± 4.6) and the highest requirement (34.9 ± 20.7) P 
< 0.05. VAS were generally satisfactory
 
for all groups, the mean score 
being below 30 mm. MAP and HR were similar in groups (D and
 
DB), 
both were significantly lower than in Group B (P< 0.05), however 
such difference was
 
not thought to be of clinical importance. The
 
motor block was more significant in-group B and DB compared with 
group D in the PACU and up to 6 h post infusion (P <0.05 compared 
with dexmedetomidine group) While sensory blockade was more 
pronounced in the combination group. He concluded that   patients 
undergoing abdominal surgery,
 the addition of the α2-adrenergic 
agonist dexmedetomidine to epidural
 
infusions of bupivacaine 
significantly improved postoperative
 
analgesia without significant side 
effects.
  
 
Antonio Mauro Vieira et.al
 
 
27
 
They conducted a study to evaluate the analgesia and sedation 
promoted by clonidine or dexmedetomidine associated to epidural 
ropivacaine in the postoperative period of subcostal cholecystectomy. 
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Clonidine and dexmedetomidine are α-2-adrenergic agonists with 
analgesic proprieties which potentiate local anaesthetic effects when 
epidurally administered. Forty patients of both gender were 
participated in this randomized double-blind study, aged 18 to 50 
years, weighing 50 to 100 kg, physical status ASA I or II, submitted to 
subcostal cholecystectomy. The subjects were distributed in two 
groups: Clonidine (CG) received clonidine (1 mL = 150 μg) associated 
to 0.75% epidural ropivacaine (20 mL); Dexmedetomidine (DG) 
received dexmedetomidine (2 μg/kg) associated to 0.75% epidural 
ropivacaine (20 mL). Analgesia and sedation were evaluated 2, 6 and 
24 hours after anesthetic recovery. Both groups presented some grade 
of sedation at 2 and 6 hours, with statistically significant difference 
between the two moments for the dexmedetomidine group. There has 
been analgesia in both groups, especially at 2 and 6hours. There has 
been statistically significant difference among periods of 2, 6 and 24 
hours in the dexmedetomidine group; in the clonidine group, this 
statistically significant difference was observed between the periods of 
2 and 6 hours and between 2 and 24 hours. To conclude that the 
association of clonidine or dexmedetomidine to 0.75% ropivacaine 
induces analgesia and sedation in 2 and 6 hours after anaesthetic 
recovery in patients submitted to subcostal cholecystectomy and that 
clonidine promotes more prolonged analgesia. 
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MATERIALS AND METHODS 
This study was a randomised prospective single blinded study. 
This was conducted with approval of institutional ethical committee 
and written informed consent of parents or guardian. Patients who 
satisfied our inclusion criteria were divided into two groups - group B 
and Group BD. 
 INCLUSION CRITERIA: 
• Age : 1year to 8 years 
• ASA : 1 & 2, 
• Surgery: Elective lower abdominal surgery  
• Duration: Less than 120 minutes 
EXCLUSION CRITERIA: 
• Patients with suspected coagulopathy and History of liver 
disease 
• Infection at the site of caudal block  
• Uncontrolled systemic disorders 
• H/O Developmental delay, Neurological disease 
• Known allergy to study drugs  
• Skeletal deformities 
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MATERIALS USED: 
• Laryngoscopes of various sizes,  
• Gum elastic bougie 
• Guedel’s oropharyngeal airway 
• Drugs –  propofol, sevoflurane, normal saline, inj 
atropine, succinylcholine ,inj ephedrine and other 
emergency drugs. 
• Monitors – ECG , NIBP, SPO2, temperature monitoring. 
• 2 cc,5 cc and 10 cc syringe 
• 22G,24 G intravenous cannula. 
• 23 G IM needle. 
• Appropriate size endotracheal tubes/ Laryngeal Mask 
airway 
• Dexmeditomidine  50 mic/ml 1ml ampoule 
• bupivacaine 20ml vial 0.5% 
PRIMARY PARAMETERS Noted were 
• Ramsay sedation scale 
• FLACC Pain Score and 
•  Duration of Analgesia 
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              SECONDARY OUTCOME MEASURES:  
• Heart rate,  
• Systolic, Diastolic, and Mean Blood Pressure , 
• SpO2 
• Any adverse effects 
CONDUCTION OF THE STUDY 
 A prospective randomized control study was done to compare 
the effect of adding dexmedetomidine to caudal bupivacaine and 
caudal bupivacaine alone for providing postoperative analgesia in 
children undergoing lower abdominal surgeries. 
 The clinical study was conducted at our hospital in 
anaesthesiology department. Sixty children between the age group 1 to 
8 years scheduled for elective lower abdominal surgeries were 
randomly divided into two groups for study. The age and weight of 
child was recorded. All children had their last feed at about 4.00am on 
the day of surgery. 
Group B-received caudal epidural block with 1ml/kg of  0.25%  
bupivacaine 
Group BD-received caudal epidural block with 1ml/kg of 0.25% 
Bupivacaine and 1microgram /kg of   dexmedetomidine 
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All the operations were carried out under general anaesthesia. 
precordial stethoscope, pulse oxymeter. NIBP,ECG,SPO2  monitors 
were attached. basal parameters were noted. Intravenous line was 
secured with 22 G  IV cannula onto a vein on the dorsum of hand. 
Anaesthesia was induced in the theatre with propofol at a dose 
of 2 mg/kg along with O2 100% with fresh gas flow of 6 L/minute 
with sevoflurane 2 to 3 %. an appropriate sized LMA was positioned 
in situ, bilateral air entry  was  checked and LMA was fixed. 
anaesthesia was maintained with 67%  N20 &33% O2 and sevoflurane 
1to 2% using  Jackson   Rees modifications of ayre’s  ‘T’ piece  with 
the patient in spontaneous respiration.  
After induction of general anaesthesia, GROUP B received 
caudal epidural block with 1ml/kg of   0.25% bupivacaine, Group BD-
received caudal epidural block with 1ml/kg of 0.25% Bupivacaine and 
1microgram /kg of   dexmedetomidine 
Using 23G needle. Intraoperatively  balanced  salt solution 
20ml/kg/hour was infused. Heart rate,respiratory rate ,blood pressure 
were recorded at an interval 5 minutes. Block failure was considered if 
rise in heart rate or MAP more than 20% of pre incision values. Inj 
fentanyl 1 mcg/kg iv was given in these patients were pain relief. 
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Children were extubated in deep plane of anaesthesia. Children 
shifted to PACU haemodynamics were continuously were monitored 
for 24 hours.   
Post-op Sedation was assessed using ramsay sedation score as 
follows:  
I. Anxious, agitated or both 
II. Co-operative oriented, tranquil  
III. Response to commands only 
IV. Brisk response to loud auditory stimulus 
V. Sluggish response to loud auditory stimulus 
VI. No response to loud auditory stimulus  
Pain was assessed by using FLACC pain scale, rescue analgesia 
of Syp. Paracetamol 15mg/kg given at pain score 4 or above. 
Pulse rate, NIBP, and complications like nausea and vomiting, 
urinary retention, and respiratory depression etc. Bradycardia was 
considered if heart rate less than 60/min and treated with injection 
atropine , hypotension was considered when  systolic blood pressure 
was below 70 plus twice age in years with altered tissue perfusion. 
Number of patients requiring fluid bolus to treat hypotension noted. 
Respiratory depression was considered if SpO2 fell below 95%. 
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Oral feeds were allowed after 6 hours. All the children were 
examined prior to discharge for clinical evaluation of neurological 
system 
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OBSERVATION AND RESULTS 
STATISTICAL ANALYSIS 
 Results are expressed as mean and standard deviation. All 
statistical analyses were carried out using SPSS for Windows version 
15.0. Statistical analysis was carried out by student’s t-test for 
parametric data and chi square test, fischer’s exact test for non 
parametric data. Heart rate, systolic, diastolic and mean arterial 
pressure were compared using student’s t-test. A p value < 0.05 was 
considered as statistically significant. 
 Both the groups were comparable in terms of age, sex, weight 
and duration of surgery. 
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Table 1: Demographic Profile: Age 
  
 
 
 
There  was  no  statistically  significant  difference  in  between  the  
two  groups  in  terms  of  age. 
1 
2 
3 
4 
5 
6 
7 
8 
Group B Group BD 
age in years 
group N Mean 
±standard 
deviation 
P value 
Group B 30 4.5±1.96  0.267 
 
Group BD 30 3.9±1.83 
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Table 2: Demographic Profile : Sex 
 
sex Group B Group BD  P value 
No % no % 
male 25 83.3 27 90 0.448 
female 5 16.7 3 10 
 
 
 
 
 
There  was  no  statistically  significant  difference  in  between  the  
two  groups  in  terms  of  sex  ratio. 
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Table no 3: Demographic Profile Weight 
 
Group N mean± standard 
deviation 
P value 
Group B 30 14.7±3.38 0.226 
Group BD 30 13.63±3.48 
 
 
 
 
There  was  no  statistically  significant  difference  in  between  the  
two  groups  in  terms  of  distribution  of  weight. 
 
 
 
 
8 
10 
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20 
group B group BD 
weight 
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Table 4: Comparison of Type of Surgery 
 
Surgery Group B Group BD P value 
no Percentage No Percentage 0.934 
circumcision 11 36.7% 10  47.6% 
herniotomy 11 36.7% 10  47.6% 
Hydrocele 5 16.7% 7 23.3% 
Orchidopexy 8 10% 3 10% 
 
.Duration of surgery 
 
 
 
 
weight 
group N mean±standard 
deviation 
P value 
Group B 30 30.8±6.8 0.127 
Group BD 30 33.3±5.6 
 
 
There  was  no  statistically  significant  difference  in  between  
the  two  groups  in  terms  of   type  of  surgery or the duration of 
surgery 
20 25 30 35 40 
group B 
group BD 
duration of surgery 
duration of surgery 
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Table 6:  Duration of Analgesia 
 
 
 
Mean duration of analgesia in group B was 307.33± 31.588 
minutes  and  in  group BD  was 682.33± 74.310 minutes .We found 
that the duration of analgesia  was  significant  better with a  p value of  
0.000.  
 
 
 
 
 
0 200 400 600 800 
group B 
group BD 
duration of analgesia (in minutes) 
duration of 
analgesia (in 
minutes) 
Group 
Mean± 
Std. Deviation 
p  value 
Group B 
307.33± 31.588 0.000 
Group BD 682.33± 74.310  
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Table 7: FLACC Score of the Two Groups 
 
Time N Group B Group BD p value 
0 hour 30 30  
0.00±.000(a) 
 
0.00±0.000(a) 
0.326 
2
nd
 hour 30 30  
.07±.365 
0.00±.000 
0.000 
4
th
 hour 30 30 
2.63±.964 
 
.03±.183 
0.000 
6
th
 hour 30 30  
3.96±.204 
 
.40±.724 
0.000 
8
th
 hour 1 30  
4.00 
 
1.83±.913 
0.027 
12
th
 hour 0 16 -  
3.88±.342 
- 
16
th
 hour 0 2 - 4.00±0.000 - 
 
Effective analgesia as indicated by the FLACC score of less 
than 4 was observed for upto 8 hours in the bupivacaine with 
dexmedetomidine group and upto 4 hours in bupivacaine with saline 
group postoperatively.   
 The   difference  in  FLACC  score   between  the  two  groups  
was  highly  significant.   
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Table 8: FLACC Score Frequency Distribution 
 
FLACC score 
hours 
zero one two three Four total 
B BD B BD B BD B BD B BD B BD 
       0 hour 30 30 - - - - - - - - 30 30 
2
nd
 hour 29 30 - - 1 - - - - - 30 30 
4
th
  hour - 29 4 1 8 - 11 - 7 - 30 30 
6
th
 hour - 22 - 4 - 4 1 - 29 - 30 30 
8
th
 hour - 3 - 6 - 14 - 7 - - - 30 
10
th
 hour - - - - - 2 - 13 - 15 - 30 
 
 
This table shows the frequency distribution of FLACC score 
among the two groups over the period of 10 hours. The FLACC Score 
was better with group BD over the entire period. 
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FLACC score measured every 4
th
 hour showed that the score 
was significantly better in group BD. 7 and 29 patients had score of 4 
in group B compared to zero patients in group BD. Score of 4 was 
attained only at the 10
th
 hour in group BD in 15 patients 
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Table 9: The Ramsay Sedation Score of the Two Groups 
 N      Group B Group BD P  value 
30MINS 30 30                            3.00±0.000(a) 5.00±0.000 0.000 
1
st
 hour 30 30 2.87±0.346 4.00±0.000 0.000 
1.5hour 30 30 2.53±0.507 3.20±0.407 0.000 
2
nd
  hour 30 30 1.97±0.183 2.73±0.521 0.000 
3
rd
  hour 30 30 1.69±0.471 2.40±0.498 0.000 
4
th
  hour 21 30 1.48±0.512 2.30±0.466 0.000 
5
th
 hour 10 30 1.50±0.527 2.13±0.434 0.000 
6
th
  hour 3 30 1.00±.000(a) 1.00±1.00 0.001 
 
 
Adequate sedation as indicated by Ramsay’s sedation score of 2 was 
observed upto 1and half hours in bupivacaine with saline group and 
upto 4 hours in the bupivacaine with dexmedetomidine group. 
This showed that the sedation was better with dexmedetomidine group 
when compared to the saline group. It was statistically significant p 
value less than 0.001 
0 
1 
2 
3 
4 
5 
6 
30MINS 1st hour 1.5hour 2nd  
hour 
3rd  hour 4th  hour 5th hour 6th  hour 
group B 
group BD 
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Table 10: Intra Operative Systolic Blood Pressure of The 
Two Groups 
 
 Group  B Group BD p  value 
Baseline 104.63±17.06 102.97±16.73 0.704 
After induction 96.3±11.32 94.4±12.92 0.547 
5 minutes 96.97±11.63 94.17±9.62 0.314 
10 minutes 97.27±8.85 93.67±10.01 0.146 
15minutes 95.60±10.92 93.73±9.94 0.492 
20minutes 95.69±9.29 92.70±9.28 0.221 
25minutes 95.52±7.81 93.53±8.59 0.367 
30 minutes 96.26±6.52 94.50±8.75 0.463 
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Table 11: Post-Operative Systolic Blood Pressure 
 
 Group  B Group BD p  value 
0 hour 93.93±6.602 94.47±8.65 0.789 
2
nd
 hour 95.47±7.89 95.90±.628 0.840 
4
th
  hour 95.47±5.47 96.10±8.462 0.755 
8
th
 hour 97.27±9.868 96.60±9.561 0.791 
12
th
 hour 96.83±8.158 96.50±9.35 0.884 
16
th
  hour 96.10±7.275 97.13±9.18 0.631 
20
th
 hour 95.27±6.66 97.57±10.21 0.307 
 24
th
 hour 95.47±7.749 98.43±98.43 0.199 
 
 
 
The systolic blood pressure was comparable between the groups 
both in the intra-operative and post-operative period. 
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Table 12: Comparison of Mean of Diastolic Blood Pressure 
Between The Two Groups- Intra-Operative Period 
 
 N Group B Group BD p value 
Baseline 30 56.17±7.12 54.97±6.89 0.051 
After 
induction 
30 56.27±6.72 54.13±2.99 0.195 
5  minutes 30 56.83±6.39 53.63±5.81 0.047 
10 minutes 30 56.83±7.33 54.37±5.38 0.159 
15 minutes 30 57.27±7.38 54.03±11.0 0.199 
20 minutes 30 56.24±7.00 56.13±6.03 0.950 
25minutes 30 56.22±6.76 56.00±6.06 0.897 
30 minutes 30 59.47±6.41 57.19±6.77 0.255 
 
 
 
 
The mean diastolic blood pressure was comparable between the 
groups  in the intra-operative period. 
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Table No 13: Comparison of Mean of Diastolic Blood Pressure 
Between The Two Groups- Post-Operative Period 
Time N Group B Group BD p value 
0 hour 30 54.27±6.55 53.87±5.34 0.652 
2
nd
 hour 30 57.00±6.98 55.17±5.65 0.268 
4
th
 hour 30 57.80±8.63 54.07±6.38 0.62 
8
th  
hour 30 55.80±6.65 55.17±7.24 0.726 
12
th
 hour 30 55.57±6.74 54.37±6.72 0.493 
16
th
 hour 30 57.07±7.34 54.60±7.00 0.194 
20
th
 hour 30 56.67±9.94 54.83±6.08 0.393 
24
th
 hour 30 55.87±6.37 55.27±5.343 0.721 
 
 
  
The mean diastolic blood pressure was comparable between the 
groups in the post-operative period. 
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Table 14: Mean Arterial Pressure Intra operative Period In Both 
The Groups 
  
 N Group B Group BD p value 
Baseline  30 74.32±9.28 70.96±9.10 0.163 
After 
induction 
30 70.94±6.67 67.55±7.32 0.060 
5 minutes 30 70.21±6.93 67.14±6.46 0.082 
10 minutes 30 70.31±7.04 67.53±5.91 0.103 
15 minutes 30 70.04±7.51 67.26±8.34 0.181 
20 minutes 30 67.07±14.31 68.32±6.00 0.663 
25 minutes 30 62.38±21.93 68.51±6.00 0.146 
30 minutes 30 67.00±7.24 68.35±5.09 0.661 
 
 
 
The mean arterial blood pressure was comparable between the 
groups both intra-operative period. 
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Table 15: Mean arterial pressure post-operative period in both the 
groups 
time N Group B Group BD p value 
O hour 30 67.68±6.05 67.40±5.80 0.851 
2
nd
 hour 30 69.82±6.44 68.74±5.63 0.632 
4
th
 hour 30 70.35±7.27 68.07±6.27 o.381 
8
th
 hour 30 69.62±6.91 68.97±7.37 0.836 
12
th
 hour 30 69.32±6.60 68.41±6.79 0.560 
16
th
  hour 30 70.07±6.70 68.77±6.39 0.493 
20
th
 hour 30 69.53±7.63 69.08±6.19 0.199 
24
th
  hour 30 70.67±6.17 69.66±5.71 0.728 
 
 
The mean blood pressure was comparable between the groups in the 
post-operative period. 
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Table 16: Comparison of Intra-operative heart rate between the 
two groups. 
 
Minutes number Group BD Group B p value 
Baseline 30 99.17±7.85 98.17±7.13 0.608 
After 
induction 
30 119±9.49 123±8.50 0.188 
5 minutes 30 106.7±8.50 118.5±9.61 0.000 
10minutes 30 103.6±7.66 113.8±8.84 0.000 
15 minutes 30 100.6±6.6 109.7±8.2 0.000 
20 minutes 30 98.69±6.53 105.07±6.78 0.001 
25minutes 30 97.44±6.75 101.6±8.1 0.016 
30 minutes 30 95.0±8.1 99.08±5.080 0.029 
 
 
 
 
There was statistically significant difference noted   between the 
two groups in intraop heart rate with p value of less then 0.05 
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Table 14: Comparison of post -operative heart rate between the 
two groups. 
 
 number Group B Group BD p  value 
0 hour 30 95.9±4.84 93.7±6.60 0.159 
2
nd
 hour 30 89.3±6.85 90.5±9.03 0.543 
4
th
 hour 30 91.03±6.18 90.63±7.41 0.821 
8
th
 hour 30 91.87±6.37 88.6±5.34 0.246 
12
th
 hour 30 91.13±6.34 89.6±5.34 0.311 
16
th
 hour 30 91.47±6.08 89.6±6.18 0.156 
20
th
 hour 30 90.97±5.85 90.7±5.48 0.856 
24
th
 hour 30 91.93±5.75 91.93±5.76 0.888 
 
 
There was no significant difference in the mean heart rate 
between the two groups in post-operative period 
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DISCUSSION 
Caudal analgesia is one of the easiest and safest technique for 
providing pain relief, both in children and adults, with a very high 
success rate.  Apart from providing adequate intra-operative and post-
operative analgesia, it is beneficial in various ways.  It reduces the 
stress hormone levels produced during anaesthesia.  It reduces the 
intraop and postop analgesic requirements in the form of narcotics and 
NSAIDs.  It also helps in early ambulation and less hospital stay, 
thereby alleviating most of the anxiety and burden of the child’s 
parents. 
Local anaesthetics alone, especially Bupivacaine, were 
commonly used in the past in caudal technique for providing pain 
relief.  Though it has produced excellent analgesia, the analgesia was 
found to be short lived and required additional analgesic requirements 
in the postoperative period.  This resulted in excessive use of opioids 
like morphine postoperatively, which resulted in significant 
respiratory depression and PONV(Post Operative Nausea and 
Vomiting).  Though caudal continuous catheter technique was found 
as an alternative to provide analgesia throughout the postoperative 
period, it had its own disadvantage of producing severe catheter 
related infections. 
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 This resulted in the usage of various adjuvants to the local 
anaesthetics to prolong their analgesic effect postoperatively, like 
morphine, adrenaline, ketamine, neostigmine, clonidine etc..  
 One such adjuvant used was dexmedetomidine, a newer alpha-2 
agonist.  This drug had various advantages when compared other 
adjuvants which were used in the past, in providing extended duration 
of analgesia with good sedation(arousable sleep) without producing 
respiratory depression, which gained its popularity in the recent time. 
 Our study was done to evaluate the analgesic efficacy of 
dexmedetomidine with bupivacaine in caudal analgesia. 
FLACC SCORE: 
 The bupivacaine with saline group(group B) and the 
bupivacaine with dexmedetomidine group(group BD) were compared 
with respect to the FLACC scores achieved at various interval of time 
( 0 hr, 2
nd
 hr, 4
th
 hr and every 4 hours thereafter).  The FLACC score 
of less than 4 was assumed as effective analgesia. 
 The FLACC score was comparable between the groups in the 
2
nd
 hour postoperatively.  After the second hour, the FLACC scores 
differed significantly between the groups(p<0.05).  At the 4
th
 hour 
postoperatively, the FLACC score in bupivacaine group was 2.6±0.9 
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and in bupivacaine with dexmedetomidine group was 0.03±0.18, 
which was  statistically significant(p=0.000).   
At the 6
th
 hour postoperatively, the FLACC score in 
bupivacaine group was 3.9±0.2 and in bupivacaine with 
dexmedetomidine group was 0.4±0.72, which was  statistically 
significant(p=0.000).  At the 8
th
 hour postoperatively, the FLACC 
score in bupivacaine group was 4 and in bupivacaine with 
dexmedetomidine group was 1.8±0.91, which was  statistically 
significant(p=0.027). 
Effective analgesia as indicated by the FLACC score of less 
than 4 was observed for upto 8 hours in the bupivacaine with 
dexmedetomidine group and upto 4 hours in bupivacaine with saline 
group postoperatively.   
This shows that the effective analgesia lasted longer in 
bupivacaine with dexmedetomidine when compared to bupivacaine 
group. 
 This finding closely correlates with the results of the study done 
by Vijay G anand et al where ropivacaine with dexmedetomidine 
attained FLACC score of 4 at 16
th
 hour and ropivacaine alone group 
attained it at 6
th
 hour postoperatively(p<0.001). 
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 This is also supported by the study done by Hannawy et al 
where FLACC score of 4 was attained at 16
th
 hour in the bupivacaine 
with dexmedetomidine (2 mcg/kg) group(p<0.001). 
          This is also supported by Sadawy et al   FLACC score of 4 was 
attained at 18.2 hour in bupivacaine with dexmedetomidine group 
compared with 2.8 hours in bupivacaine group. 
SEDATION SCORE: 
 Sedation score was analysed between the two groups at various 
interval of time( 30
th
 min, 1
st
 hr, 1.5
th
 hr, 2
nd
 hr, 3
rd
 hr, 4
th
 hr, 5
th
 hr and 
6
th
 hr postoperatively). Ramsay’s sedation score of atleast 2(co-
operative, oriented, tranquil) was assumed as adequate sedation. 
- No patient had sedation score of 6(unresponsive patient). 
- At 30th minute, the sedation score observed was 3 in the 
bupivacaine group and 5 in the bupivacaine with 
dexmedetomidine group. 
- At 1st hour postoperative period, the sedation score observed 
was 2.87±0.34 in the bupivacaine group and 4 in the 
bupivacaine with dexmedetomidine group, which was  
statistically significant(p=0.000) 
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- At 1.5th hour postoperative period, the sedation score 
observed was 2.03±0.50 in the bupivacaine group and 
3.20±0.4 in the bupivacaine with dexmedetomidine group, 
which was  statistically significant(p=0.000) 
- At 2nd hour postoperative period, the sedation score observed 
was 1.97±0.18 in the bupivacaine group and 2.73±0.52 in the 
bupivacaine with dexmedetomidine group, which was 
statistically significant(p=0.000) 
- At 3rd hour postoperative period, the sedation score observed 
was 1.69±0.47 in the bupivacaine group and 2.47±0.49 in the 
bupivacaine with dexmedetomidine group, which was 
statistically significant(p=0.000) 
- At 4th hour postoperative period, the sedation score observed 
was 1.48±0.51 in the bupivacaine group and 2.30±0.46 in the 
bupivacaine with dexmedetomidine group, which was found 
to be statistically significant(p=0.000) 
- At 5th hour postoperative period, the sedation score observed 
was 1.5±0.52 in the bupivacaine group and 2.13±0.43 in the 
bupivacaine with dexmedetomidine group, which was found 
to be statistically significant(p=0.001) 
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Adequate sedation as indicated by Ramsay’s sedation score 
of 2 was observed upto 1and half hours in bupivacaine with 
saline group and upto 4 hours in the bupivacaine with 
dexmedetomidine group. 
This showed that the sedation was better with 
dexmedtomidine group when compared to the saline group. 
 The results were similar to the study conducted by Vijay G 
Anand et al, where they have found that the sedation score was better 
with the ropivacaine-dexmedetomidine group when compared to 
ropivacaine alone. 
This results were similar to the study conducted by Sadawy  
et al., Hennawy et al dexmedetomidine group have better sedation 
score compared to bupivacaine group. 
DURATION OF ANALGESIA: 
The duration of analgesia was compared between the groups.  
For bupivacaine with saline group, the mean duration of analgesia was 
about  307±31 mins and for the bupivacaine with dexmedetomidine 
group, it was about 682±74 mins.  This difference was  statistically 
significant with a p value of about 0.000. 
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 This closely correlates with the Vijay G Anand et al study, 
where the duration of analgesia was higher in the ropivacaine with 
dexmedetomidine group(14.5hrs) when compared to the ropivacaine 
alone group(5.5hrs), which was statistically significant(p<0.001).  The 
longer duration of analgesia in dexmedetomidine group in this study 
when compared to our study, might probably be due to the varying 
amount of dexedetomidine administered (2 mcg/kg in this study and 
1mcg/kg in our study). 
HEMODYNAMIC CHANGES: 
The heart rate changes were compared at various interval of 
time both intra operatively and postoperatively. The changes were 
statistically significant(p<0.05) between the groups in the first half an 
hour of the surgery, where the heart rate was less in bupivacaine with 
dexmedetomidine group when compared to bupivacaine group.  But 
these heart rate changes were manageable intraoperatively, without the 
need for inj. Atropine or any inotropic support. 
Observation made in our study also concurs with Hennawy et 
al study regarding intra op significant decrease in heart rate. But the 
heart rate reduction in our study did not warrant the use of Inj 
Atropine like theirs. 
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 There were no significant difference between the groups in 
terms of systolic blood pressure, diastolic blood pressure, mean 
arterial pressure and oxygen saturation. 
These results were similar with Hennawy et al., Vijay anand 
et al., regarding of systolic blood pressure, diastolic blood pressure, 
mean arterial pressure and oxygen saturation. 
COMPLICATIONS: 
 No clinically significant complications noted in both the groups. 
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SUMMARY 
 This study was conducted to evaluate the efficacy of 
dexmedetomidine as an adjuvant to Bupivacaine in caudal analgesia 
for paediatric patients undergoing lower abdominal surgeries. 
The following observations were made 
- Duration of analgesia was higher in bupivacaine with 
dexmedetomidine (307 minutes)group when compared to the 
bupivacaine group(682 mins), which was statistically 
significant. 
- FLACC scores  for analgesic assessment was better in the 
bupivacaine with dexmedetomidine group  when compared 
to bupivacaine group which was statistically significant. 
FLACC score less than 4 was seen for upto 8 hours in the 
group BD than group B which was upto 4 hours.  
- Sedation score as assessed by Ramsay’s sedation score was 
better with the bupivacaine with dexmedetomidine group  
when compared to the bupivacaine group  which was 
statistically significant.   
- Hemodynamic changes were minimal and manageable in 
both the groups. 
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CONCLUSION 
 We conclude that addition of Dexmedetomidine as an adjuvant 
to Bupivacaine provides prolonged analgesia and better quality of 
sedation with minimal hemodynamic changes when compared to 
Bupivacaine in caudal block for paediatric patients undergoing lower 
abdominal surgeries. 
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 GROUP-B 
   
Control 
 
MASTER CHART 
SL NO 
  
NAME 
  
AGE SEX WT IP NO SURGERY DOS 
HEART RATE SYSTOLIC BP 
PERIOP POSTOP PERIOP POSTOP 
BI AI 5' 10' 15' 20' 25' 30' 35' 40' 0' 2h 4h 8h 12h 16h 20h 24h BI AI 5' 10' 15' 20' 25' 30' 35' 40' 0' 2h 4h 8h 12h 16h 20h 24h 
1 rajesh 4 m 15 2093/12 circumcision 25 94 122 118 108 99 93 88 
   
90 76 94 96 92 100 90 102 84 93 88 86 90 85 88 
   
88 85 86 87 86 90 92 90 
2 regan 4.5 m 13 2066/12 herniotomy 35 102 128 122 118 108 104 102 98 94 
 
97 91 98 100 101 96 90 93 100 108 94 98 101 98 94 96 97 
 
97 92 100 104 104 108 101 102 
3 abdul 5 m 20 2022/12 circumcision 20 96 113 106 102 96 94 
    
94 94 97 100 92 95 91 93 107 100 90 94 96 97 
    
98 97 91 98 100 102 100 104 
4 vignesh 8 m 20 2088/12 herniotomy 40 88 132 114 103 102 108 102 99 94 95 99 92 98 103 93 88 90 93 122 106 102 97 94 95 97 99 100 100 104 94 91 97 100 92 94 110 
5 dhinesh 1 m 8 2086/12 hydrocele 25 114 122 108 108 109 106 107 
   
109 103 104 107 106 105 103 100 80 76 78 87 84 80 81 
   
79 81 84 83 81 88 86 83 
6 hari 2 m 10 2078/12 herniotomy 30 102 130 120 118 108 104 106 101 
  
98 103 96 94 99 95 97 99 82 84 82 88 89 86 82 85 
  
80 79 78 76 81 83 80 81 
7 vasu 3 m 14 2067/12 circumcision 20 102 110 102 98 96 96 
    
95 90 89 91 92 94 98 96 87 83 88 90 91 82 
    
88 83 83 85 79 80 81 78 
8 rahul 3 m 13 2015/12 orchidopexy 40 90 108 104 101 94 91 88 84 83 82 80 82 85 83 82 83 82 90 96 80 78 86 82 80 83 80 87 88 82 92 93 100 95 95 88 87 
9 arun 7 m 18 2111/12 hydrocele 30 88 100 96 95 97 93 95 88 
  
80 76 80 85 86 89 91 94 114 112 116 110 113 109 104 100 
  
99 103 106 109 114 108 105 106 
10 nithyasree 3 f 12 2114/12 herniotomy 35 95 98 96 95 94 95 96 
   
90 89 95 96 97 98 100 96 90 95 92 88 89 85 89 
   
86 91 96 100 94 93 91 96 
11 mohan 3 m 12 2116/12 circumcision 15 95 110 106 101 98 
     
98 89 81 91 98 92 97 93 94 90 89 91 96 
     
92 94 97 100 93 95 94 89 
12 samson 2 m 10 2130/12 hydrocele 30 95 114 112 108 106 104 98 94 
  
94 86 88 92 95 87 87 90 90 80 94 92 83 86 91 97 
  
91 91 94 96 94 92 88 99 
13 kishore 3 m 12 2210/12 orchidopexy 40 100 122 113 116 110 108 106 107 104 106 100 95 96 95 94 93 90 89 100 102 96 98 94 96 95 97 92 96 91 92 91 93 96 98 96 96 
14 abishek 2 m 9 2215/12 circumcision 25 98 116 106 102 100 102 103 
   
102 96 92 90 95 98 97 98 88 85 86 87 83 86 84 
   
87 87 86 89 87 86 84 87 
15 raj 8 m 18 2300/12 herniotomy 35 84 85 87 86 82 80 79 72 76 
 
81 87 88 86 84 87 86 85 120 126 108 104 106 105 107 102 103 
 
100 94 98 100 102 110 96 94 
16 munisha 8 f 20 2317/12 herniotomy 30 90 108 106 102 98 96 95 97 
  
90 79 90 91 93 84 89 91 105 110 120 106 104 102 99 96 
  
94 110 98 110 106 104 103 102 
17 pradeep 3 m 12 2340/12 circumcision 35 100 120 114 116 108 105 104 102 100 
 
96 96 95 96 99 96 89 88 95 96 90 88 86 87 89 85 86 
 
90 92 93 95 92 91 92 88 
18 sakthivel 4 m 15 2318/12 orchidopexy 40 90 115 108 107 105 104 103 105 104 107 102 97 95 94 96 98 95 90 96 110 108 107 105 102 103 105 105 104 102 96 97 98 102 100 97 98 
19 hemakumar 4 m 14 2355/12 circumcision 25 90 96 94 97 96 92 90 
   
88 85 94 90 82 98 94 97 90 85 88 91 94 96 97 
   
98 97 95 102 100 98 97 95 
20 jeeva 4 m 13 2333/12 hydrocele 25 90 105 108 102 101 99 98 
   
95 95 99 92 94 94 92 93 98 100 96 95 98 94 96 
   
100 107 106 102 99 97 95 97 
21 guru 4 m 15 2341/12 herniotomy 30 88 106 108 106 102 100 99 96 
  
96 93 92 98 92 94 96 98 110 96 98 100 62 95 97 98 
  
95 98 99 104 95 96 97 93 
22 jothi 5 f 18 2347/12 herniotomy 35 86 99 93 96 97 95 94 92 93 
 
93 89 88 82 84 83 82 81 114 96 100 102 98 99 101 98 98 
 
98 98 95 104 99 94 97 96 
23 seenu 5 m 17 2317/12 circumcision 35 86 99 96 97 94 95 97 96 95 
 
90 82 81 80 86 90 82 84 116 100 96 98 101 108 106 102 103 
 
96 100 102 110 103 96 98 97 
24 karthiga 5 f 17 2318/12 herniotomy 40 80 102 101 99 98 96 94 96 91 92 90 80 79 82 86 91 94 88 110 90 92 96 94 100 97 98 99 98 94 97 100 107 103 97 99 95 
25 daniel 4 m 15 2311/12 circumcision 40 95 118 112 105 107 102 101 99 98 97 95 91 95 96 90 94 97 93 108 90 96 98 99 100 104 102 101 99 98 93 94 94 95 100 101 103 
26 saranya 4 f 13 2319/12 herniotomy 35 90 119 114 112 110 106 102 101 98 
 
95 88 86 85 84 86 87 88 116 90 94 95 99 100 90 92 90 
 
96 100 102 99 95 89 99 92 
27 goutham 5.5 m 20 2365/12 circumcision 30 86 102 98 96 94 92 90 89 
  
89 90 91 92 86 86 90 92 122 110 124 120 115 114 102 101 
  
95 104 107 105 101 99 97 95 
28 ajith 8 m 18 2379/12 hydrocele 25 90 115 114 112 108 105 102 
   
100 93 90 89 85 88 91 96 125 100 112 114 108 96 95 
   
98 106 102 108 110 108 104 107 
29 robert 7 m 16 2377/12 herniotomy 30 85 102 101 99 95 94 90 89 
  
88 86 84 88 86 80 82 86 118 100 112 108 106 102 100 96 
  
98 110 96 68 103 95 104 102 
30 kamalesh 6 m 15 2381/12 circumcision 25 90 107 105 104 107 103 102 
   
99 86 91 92 85 82 80 76 162 96 102 104 108 110 108 
   
104 101 104 95 96 99 102 102 
 
 
 
 
 SL NO 
DIASTOLIC BP MAP SpO2 
PERIOP POSTOP PERIOP POSTOP PERIOP POSTOP 
BI AI 5' 10' 15' 20' 25' 30' 35' 40' 0' 2h 4h 8h 12h 16h 20h 24h BI AI 5' 10' 15' 20' 25' 30' 35' 40' 0' 2h 4h 8h 12h 16h 20h 24h BI AI 5' 10' 15' 20' 25' 30' 35' 40' 0' 2h 6h 8h 12h 16h 20h 24h 
1 49 47 52 55 49 42 44 
   
48 44 53 51 47 46 50 48 61 62 64 65 63 56 59 
   
61 58 64 63 60 61 64 62 99 99 99 99 99 99 99 
   
99 99 99 99 99 99 99 99 
2 64 68 54 55 62 60 58 59 61 
 
66 59 54 55 60 62 66 63 76 81 67 69 75 73 70 71 73 
 
76 70 69 71 75 77 78 76 99 99 99 99 99 99 98 99 99 
 
99 99 99 99 99 99 99 99 
3 66 55 52 50 56 59 
    
60 61 63 55 61 64 68 62 80 70 65 65 69 72 0 0 0 0 73 73 72 69 74 77 79 76 99 99 99 99 99 99 
    
99 99 99 99 99 99 99 99 
4 70 67 71 64 66 61 63 69 70 
 
67 53 57 67 69 70 71 68 87 80 81 75 75 72 74 79 80 33 79 67 68 77 79 77 79 82 99 99 99 99 99 99 98 99 99 99 99 99 99 99 99 99 99 99 
5 46 48 44 40 44 46 50 
   
47 47 44 48 47 44 43 49 57 57 55 56 57 57 60 0 0 0 58 58 57 60 58 59 57 60 99 99 99 99 99 99 99 
   
99 99 99 98 99 99 99 99 
6 55 60 58 56 48 49 54 57 
  
49 48 50 50 46 44 42 48 64 68 66 67 62 61 63 66 0 0 59 58 59 59 58 57 55 59 99 99 99 99 99 99 99 99 
  
98 99 99 99 99 99 99 99 
7 55 60 48 46 48 51 
    
44 50 51 47 48 49 46 52 66 68 61 61 62 61 0 0 0 0 59 61 62 60 58 59 58 61 99 99 99 99 99 99 
    
99 99 99 99 99 98 99 99 
8 70 56 58 53 52 58 45 48 49 50 44 47 49 44 48 52 53 56 79 64 65 64 62 65 58 59 62 63 57 62 64 63 64 66 65 66 99 99 99 99 99 99 99 98 98 99 99 99 99 99 99 99 99 99 
9 65 59 64 70 71 68 64 69 
  
59 62 67 70 56 59 60 67 81 77 81 83 85 82 77 79 0 0 72 76 80 83 75 75 75 80 99 99 99 99 99 99 98 99 
  
99 99 99 99 99 99 99 99 
10 55 51 52 53 57 45 48 
   
52 57 56 54 55 57 58 59 67 66 65 65 68 58 62 0 0 0 63 68 69 69 68 69 69 71 99 99 99 99 99 99 99 99 99 
 
99 99 99 99 99 99 99 99 
11 55 56 50 51 56 
     
51 45 55 54 47 49 54 55 68 67 63 64 69 0 0 0 0 0 65 61 69 69 62 64 67 66 99 99 99 99 99 
     
99 99 99 99 99 99 99 99 
12 56 49 54 53 55 58 61 63 
  
51 61 57 55 45 49 51 53 67 59 67 66 64 67 71 74 0 0 64 71 69 69 61 63 63 68 99 99 99 99 99 99 99 99 
  
99 99 99 99 99 99 99 99 
13 56 58 59 70 64 64 61 66 63 61 56 60 57 59 52 51 50 50 71 73 71 79 74 75 72 76 73 73 68 71 68 70 67 67 65 65 99 99 99 99 99 99 99 99 98 99 99 99 99 98 97 99 99 99 
14 46 48 47 44 42 47 45 
   
47 56 47 43 49 47 48 48 60 60 60 58 56 60 58 0 0 0 60 66 60 58 62 60 60 61 99 99 99 99 99 98 99 
   
99 99 99 99 99 99 99 99 
15 49 51 57 56 59 60 54 55 53 
 
48 57 54 55 56 63 62 64 73 76 74 72 75 75 72 71 70 0 65 69 69 70 71 79 73 74 99 99 99 99 99 99 99 99 99 
 
99 99 99 99 99 99 99 99 
16 64 66 56 59 68 62 57 59 
  
47 56 58 59 57 53 58 67 78 81 77 75 80 75 71 71 0 0 63 74 71 76 73 70 73 79 99 99 99 99 99 99 99 99 
  
99 99 99 99 99 99 99 99 
17 55 54 51 53 52 58 60 61 62 
 
59 68 58 57 58 54 60 61 68 68 64 65 63 68 70 69 70 0 69 76 70 70 69 66 71 70 99 99 99 99 99 99 99 99 99 
 
99 98 99 99 99 98 99 99 
18 49 51 52 55 56 57 58 59 61 64 61 57 59 61 62 64 65 59 65 71 71 72 72 72 73 74 76 77 75 70 72 73 75 76 76 72 99 99 99 99 99 98 99 99 99 99 99 99 99 99 99 99 99 99 
19 55 56 54 49 48 44 47 
   
54 61 62 59 60 63 57 55 67 66 65 63 63 61 64 0 0 0 69 73 73 73 73 75 70 68 99 99 99 99 99 99 99 
   
99 99 99 99 98 99 99 99 
20 56 68 60 59 58 54 57 
   
49 61 65 57 59 61 65 64 70 79 72 71 71 67 70 0 0 0 66 76 79 72 72 73 75 75 99 99 99 99 99 99 99 
   
99 99 99 99 99 99 99 99 
21 65 67 64 67 58 57 59 60 
  
52 51 52 57 59 60 58 57 80 77 75 78 59 70 72 73 0 0 66 67 68 73 71 72 71 69 99 99 99 99 99 99 99 99 
  
98 99 99 99 99 99 99 99 
22 64 62 61 62 59 58 57 61 62 
 
67 71 71 68 64 65 69 58 81 73 74 75 72 72 72 73 74 0 77 80 79 80 76 75 78 71 99 99 99 99 99 99 98 99 99 
 
99 99 99 99 99 99 99 99 
23 64 64 63 67 70 71 69 68 62 
 
56 61 67 59 64 63 62 67 81 76 74 77 80 83 81 79 76 0 69 74 79 76 77 74 74 77 99 99 99 99 99 99 99 99 99 
 
99 99 99 99 99 99 99 99 
24 67 64 65 63 62 58 54 47 49 58 57 55 56 58 64 67 66 62 81 73 74 74 73 72 68 64 66 71 69 69 71 74 77 77 77 73 99 99 99 99 99 99 98 98 98 99 99 99 99 99 99 99 99 99 
25 65 62 61 54 55 57 56 57 59 61 57 55 53 54 51 58 60 54 79 71 73 69 70 71 72 72 73 74 71 68 67 67 66 72 74 70 99 99 99 99 99 99 99 99 99 99 99 99 99 99 99 99 99 99 
26 55 52 56 61 63 64 68 55 56 
 
55 61 59 54 56 58 59 57 75 65 69 72 75 76 75 67 67 0 69 74 73 69 69 68 72 69 99 99 99 99 99 99 99 99 99 
 
99 99 99 99 99 99 99 99 
27 64 60 56 64 67 52 49 52 
  
55 72 65 66 62 68 66 64 83 77 79 83 83 73 67 68 0 0 68 83 79 79 75 78 76 74 99 99 99 99 99 99 99 99 
  
99 99 99 99 99 99 99 99 
28 65 66 64 62 56 58 59 
   
56 58 89 60 64 65 53 54 85 77 80 79 73 71 71 0 0 0 70 74 93 76 79 79 70 72 99 99 99 99 99 99 99 
   
99 99 99 98 99 99 99 99 
29 65 67 68 56 58 59 63 65 
  
62 62 57 50 49 52 23 59 83 78 83 73 74 73 75 75 0 0 74 78 70 56 67 66 50 73 99 99 99 99 99 99 99 99 
  
99 99 99 99 99 99 99 99 
30 65 56 54 58 59 54 58 
   
61 54 49 48 52 55 57 68 97 69 70 73 75 73 75 0 0 0 75 70 67 64 67 70 72 79 99 99 99 99 99 99 99 
   
99 99 99 99 99 99 99 99 
 
 
 
 
 GROUP-B 
               
SL NO 
PAIN SCORE(FLACC) 
DURATION OF ANALGESIA  
sedation score PONV RTN OF URINE 
POSTOP 
  
    
    
  
 0 2h 4h 6h 8h 30 60 1.5h 2h 3h 4h 5h 6h   
 1 0 0 3 4 
 
315 3 2 3 1 
    
NIL NIL 
2 0 0 3 4 
 
325 3 3 2 2 1 
   
NIL NIL 
3 0 0 2 4 
 
330 3 3 2 2 2 1 
  
NIL NIL 
4 0 0 3 4 
 
300 3 3 2 2 2 2 1 
 
NIL NIL 
5 0 0 4 
  
260 3 3 2 2 1 2 2 1 NIL NIL 
6 0 0 2 4 
 
315 3 3 3 2 2 2 2 1 NIL NIL 
7 0 0 3 4 
 
335 3 3 2 2 1 
   
NIL NIL 
8 0 0 4 
  
260 3 3 3 2 2 2 1 
 
NIL NIL 
9 0 0 4 
  
250 3 3 3 2 2 1 
  
NIL NIL 
10 0 0 1 4 
 
315 3 3 2 2 2 1 
  
NIL NIL 
11 0 0 3 4 
 
330 3 3 3 2 2 1 
  
NIL NIL 
12 0 0 3 4 
 
340 3 3 3 2 2 1 
  
NIL NIL 
13 0 0 2 4 
 
320 3 3 2 2 2 1 
  
NIL NIL 
14 0 0 4 
  
280 3 3 2 2 2 1 
  
NIL NIL 
15 0 0 2 4 
 
310 3 2 2 2 2 2 
  
NIL NIL 
16 0 0 3 4 
 
325 3 3 2 2 2 1 
  
NIL NIL 
17 0 0 3 4 
 
310 3 3 3 2 2 2 1 
 
NIL NIL 
18 0 0 1 4 
 
335 3 3 3 2 2 1 2 
 
NIL NIL 
19 0 0 2 4 
 
310 3 3 3 2 2 2 2 
 
NIL NIL 
20 0 0 3 4 
 
340 3 3 3 2 2 1 
  
NIL NIL 
21 0 0 2 4 
 
320 3 3 3 2 1 
   
NIL NIL 
22 0 0 4 
  
260 3 3 3 2 1 
   
NIL NIL 
23 0 0 2 4 
 
340 3 3 3 2 1 
   
NIL NIL 
24 0 0 1 4 
 
310 3 3 2 2 1 
   
NIL NIL 
25 0 0 4 
  
220 3 3 3 2 1 
   
NIL NIL 
26 0 0 2 4 
 
280 3 3 3 2 2 1 
  
NIL NIL 
27 0 0 2 4 
 
305 3 2 2 2 1 
   
NIL NIL 
28 0 0 3 4 
 
315 3 2 2 2 2 2 1 
 
NIL NIL 
29 0 0 1 3 4 360 3 3 3 2 2 2 2 1 NIL NIL 
30 0 2 3 4 
 
305 3 3 2 2 2 2 1 
 
NIL NIL 
 
 
 
 
 GROUP - BD MASTER CHART 
SL NO 
  
AGE SEX WT IP NO SURGERY DOS 
HEART RATE SYSTOLIC BP 
NAME PERIOP POSTOP PERIOP POSTOP 
  BI AI 5' 10' 15' 20' 25' 30' 35' 40' 45' 50' 0' 2h 4h 8h 12h 16h 20h 24h BI AI 5' 10' 15' 20' 25' 30' 35' 40' 50' 0' 2h 4h 8h 12h 16h 20h 24h 
1 sivakumar 5 m 15 2388/12 herniotomy 35 90 109 105 100 98 95 90 98 94 
   
90 70 80 84 86 88 90 91 114 90 91 88 92 94 88 90 98 
  
90 97 92 101 96 94 95 99 
2 sabarish 2 m 10 2392/12 circumcision 30 100 135 130 126 124 114 108 102 
    
95 70 76 88 92 94 96 97 80 72 75 78 81 82 80 85 
   
80 91 92 94 88 86 82 86 
3 kalaibarathi 1.5 f 8 2398/12 herniotomy 40 102 133 133 124 114 108 104 100 96 99 
  
90 92 88 91 93 94 97 99 80 76 82 78 76 78 80 82 86 84 
 
80 85 79 84 80 79 78 81 
4 aarthi 5 f 20 2400/12 hydrocele 30 86 125 122 116 108 102 101 98 
    
95 83 91 92 94 93 90 97 116 94 100 102 104 105 105 100 98 102 
 
102 96 94 96 98 100 108 102 
5 kishore 1 m 10 2412/12 circumcision 35 111 132 126 122 118 108 105 107 104 
   
99 83 79 86 88 9 94 98 76 74 80 82 86 85 84 79 82 
  
79 80 82 81 80 79 78 79 
6 kamalesh 6 m 15 2415/12 herniotomy 40 89 104 101 99 97 96 92 88 86 89 
  
88 84 82 90 92 91 96 95 125 100 96 92 94 98 96 98 99 97 
 
95 100 112 98 96 97 102 105 
7 anandh 7 m 22 2417/12 hydrocele 30 86 114 108 104 98 96 92 90 
    
88 92 90 96 94 97 99 95 126 102 103 100 96 94 98 102 
   
98 105 98 102 95 96 98 96 
8 kalidas 4 m 12 2418/12 circumcision 35 98 130 128 122 120 109 100 98 
    
96 88 86 92 93 96 94 94 126 122 108 106 104 100 98 102 104 
  
108 105 104 110 108 102 98 96 
9 rahul 4 m 16 2467/12 herniotomy 40 95 126 120 109 105 102 105 106 107 99 
  
98 91 92 94 94 96 97 94 100 90 86 92 95 92 90 89 96 98 
 
98 106 100 96 108 114 116 112 
10 nazir 2 m 12 2430/12 orchidopexy 40 98 126 122 118 108 105 103 100 98 96 
  
95 88 86 95 92 94 92 98 85 84 82 80 76 78 78 81 83 85 
 
88 85 86 90 94 96 88 95 
11 bharath 5 m 17 2439/12 circumcision 30 96 118 115 114 110 108 104 100 
    
96 88 91 98 95 99 92 94 91 92 95 100 95 98 97 96 
   
94 103 102 103 114 112 113 108 
12 tharunmani 4 m 15 2455/12 hydrocele 30 99 126 122 109 105 104 99 95 
    
95 91 93 95 94 91 93 95 102 103 105 110 118 106 106 108 
   
100 108 104 110 105 104 103 101 
13 sarath 3 m 14 2459/12 herniotomy 30 102 126 122 114 110 105 102 98 
    
96 86 84 87 86 85 91 92 98 90 88 95 96 100 104 97 
   
98 89 100 102 98 95 98 99 
14 joshva 1 m 8 2471/12 circumcision 25 106 135 125 120 114 114 108 
     
104 86 88 92 94 95 91 90 78 79 80 82 85 78 79 
    
80 80 79 72 76 81 83 80 
15 ferhose 3.5 m 10 2481/12 hydrocele 30 101 128 124 116 108 104 101 99 
    
96 78 85 82 80 78 76 78 114 100 98 96 94 92 98 104 
   
96 96 92 90 93 100 96 95 
16 manikandan 6 m 16 2491/12 orchidopexy 40 88 108 106 104 102 101 95 95 96 92 
  
87 74 82 84 88 82 86 88 124 100 102 104 113 108 102 100 98 105 
 
98 101 105 108 100 98 95 99 
17 kannan 6 m 15 2503/12 herniotomy 30 90 117 108 106 102 98 95 97 
    
95 88 80 86 89 91 92 89 100 96 98 102 104 98 96 97 
   
98 105 100 98 96 101 108 110 
18 sunil 4 m 14 2509/12 circumcision 30 110 126 125 115 108 100 98 96 
    
94 92 85 92 94 93 88 91 110 92 96 98 97 105 106 
    
98 97 103 107 110 98 95 96 
19 ramkumar 7 m 18 2522/12 hydrocele 35 98 118 108 106 104 102 100 96 
    
94 88 86 81 80 79 78 81 124 110 106 102 100 98 96 99 101 
  
112 106 103 98 107 109 108 110 
20 prashanth 2 m 10 2529/12 orchidopexy 50 110 132 128 126 120 114 104 102 108 102 98 98 96 84 82 86 97 91 95 94 86 80 82 81 83 82 85 81 86 84 82 83 83 87 85 86 91 93 95 
21 mohanraj 5 m 14 2535/12 circumcision 25 100 116 96 94 92 91 96 
     
91 86 87 91 90 92 93 96 110 106 98 103 104 105 100 
    
96 94 97 92 99 94 96 94 
22 vimal 2 m 9 2539/12 circumcision 25 102 119 118 116 110 110 108 
     
104 86 91 94 96 97 92 97 92 84 86 84 84 82 86 
    
86 85 88 87 86 88 92 93 
23 sarath 6 m 16 2542/12 herniotomy 35 99 128 124 118 114 108 102 104 101 
   
101 84 78 83 82 80 88 91 121 108 105 102 100 102 108 112 116 
  
108 102 105 107 98 103 105 112 
24 vignesh 5 m 15 2547/12 hydrocele 30 95 114 112 110 106 104 100 98 
    
96 88 84 82 83 91 95 92 116 112 108 112 96 92 96 99 
   
96 97 105 112 101 104 99 107 
25 vetri 7 m 17 2544/12 herniotomy 35 90 119 115 112 108 104 103 100 98 
   
96 88 86 91 95 92 91 89 126 114 108 102 99 96 94 102 108 
  
104 108 103 105 106 108 114 109 
26 silambu 3 m 12 2564/12 circumcision 30 98 121 116 112 108 104 102 98 
    
96 88 86 91 88 86 88 87 91 93 95 85 91 88 93 90 
   
92 94 95 98 102 106 103 106 
27 karthiga 4 f 15 2567/12 herniotomy 40 92 115 112 108 104 102 100 98 96 99 
  
96 88 86 91 93 92 91 90 108 112 102 96 92 90 95 96 102 106 
 
102 104 101 96 98 99 103 104 
28 siddharth 2 m 10 2567/12 circumcision 30 106 135 132 130 126 121 116 108 
    
102 92 90 88 85 79 82 88 80 79 91 84 86 82 87 88 
   
88 86 88 84 86 84 83 79 
29 david 3 m 14 2601/12 hydrocele 35 100 123 122 118 109 105 102 101 105 
   
100 82 80 78 81 76 82 82 96 89 91 88 87 91 94 94 97 
  
94 96 98 97 100 103 105 107 
30 alagu 2.5 m 10 2615/12 herniotomy 30 108 132 131 126 122 118 114 112 
    
108 95 86 78 80 88 92 96 94 89 88 86 84 82 87 86 
   
93 93 89 95 91 93 92 98 
 
 
 
 
 group-BD 
                                                        
SL NO 
DIASTOLIC BP 
 MAP SpO2 
PERIOP POSTOP PERIOP POSTOP PERIOP POSTOP 
 BI AI 5' 10' 15' 20' 25' 30' 35' 40' 0' 2h 4h 8h 12h 16h 20h 24h BI AI 5' 10' 15' 20' 25' 30' 35' 40' 0' 2h 4h 8h 12h 16h 20h 24h BI AI 5' 10' 15' 20' 25' 30' 35' 40' 0' 2h 6h 8h 12h 16h 20h 24h 
1 65 48 44 47 48 57 55 52 60  58 53 61 65 66 69 62 60 81 62 60 61 63 69 66 65 73  69 67.7 71.3 77 76 77.3 73 73 99 99 99 99 99 99 99 99 99  99 99 99 99 99 99 99 99 
2 46 47 42 51 51 50 57 50   44 44 47 42 44 47 47 51 57 55 53 60 61 61 65 62   56 59.7 62 59.3 58.7 60 58.7 62.7 99 99 99 99 99 99 99 99   99 99 99 99 99 99 99 99 
3 46 48 47 45 49 46 44 42 47 45 42 50 49 47 45 44 46 49 57 57 59 56 58 57 56 55 60 58 55 61.7 59 59.3 56.7 55.7 56.7 59.7 99 99 99 99 99 99 99 98 98 99 99 99 99 99 99 99 99 99 
4 64 60 56 58 57 58 59 62   58 61 63 64 58 57 54 56 81 71 71 73 73 74 74 75 33 34 73 72.7 73.3 74.7 71.3 71.3 72 71.3 99 99 99 99 99 99 99 99 98 99 99 99 99 99 99 99 99 99 
5 46 45 47 44 47 46 44 48 46  45 53 49 48 46 47 48 51 56 55 58 57 60 59 57 58 58  56 62 60 59 57.3 57.7 58 60.3 99 99 99 99 99 99 98 99 99  99 99 99 99 99 99 99 99 
6 55 56 58 57 49 51 54 58 61 65 56 58 59 61 63 67 68 66 78 71 71 69 64 67 68 71 74 76 69 72 76.7 73.3 74 77 79.3 79 99 99 99 99 99 99 99 99 99 98 99 99 99 99 99 99 99 99 
7 56 56 61 60 67 62 64 66   60 58 59 61 60 64 62 60 79 71 75 73 77 73 75 78   73 73.7 72 74.7 71.7 74.7 74 72 99 99 99 99 99 99 99 99   99 99 99 99 99 99 99 99 
8 56 58 61 64 63 65 66 67 70  56 63 56 59 57 58 62 60 79 79 77 78 77 77 77 79 81  73 77 72 76 74 72.7 74 72 99 99 99 99 99 99 99 99 99  99 99 99 99 99 99 99 99 
9 61 62 58 56 54 55 58 59 62 64 58 58 54 54 57 55 52 58 74 71 67 68 68 67 69 69 73 75 71 74 69.3 68 74 74.7 73.3 76 99 99 99 99 99 99 99 99 99 99 99 99 99 99 99 99 99 99 
10 56 58 60 62 63 64 62 59 58 57 46 51 49 48 50 52 55 54 66 67 67 68 67 69 67 66 66 66 60 62.3 61.3 62 64.7 66.7 66 67.7 99 99 99 99 99 99 99 99 99 99 99 99 99 99 99 99 99 99 
11 56 58 54 55 61 59 63 67   58 51 52 53 52 55 51 49 68 69 68 70 72 72 74 77   70 68.3 68.7 69.7 72.7 74 71.7 68.7 99 99 99 99 99 99 99 99   99 99 99 99 99 99 99 99 
12 56 52 52 51 49 52 56 55   55 51 55 59 57 52 57 59 71 69 70 71 72 70 73 73   70 70 71.3 76 73 69.3 72.3 73 99 99 99 99 99 99 99 99   99 99 99 99 99 99 99 99 
13 54 52 49 48 50 56 62 61   54 58 51 50 54 55 56 57 69 65 62 64 65 71 76 73   69 68.3 67.3 67.3 68.7 68.3 70 71 99 99 99 99 99 99 99 99   99 99 99 99 99 99 99 99 
14 45 48 44 51 53 47 44    49 51 52 50 47 48 45 44 56 58 56 61 64 57 56    59 60.7 61 57.3 56.7 59 57.7 56 99 99 99 99 99 99 99    99 99 99 99 99 99 99 99 
15 51 53 55 49 48 47 51 56   51 46 44 50 53 58 46 43 72 69 69 65 63 62 67 72   66 62.7 60 63.3 66.3 72 62.7 60.3 99 99 99 99 99 99 99 99   99 99 99 99 99 99 99 99 
16 54 50 58 57 66 64 63 62 59 58 54 62 60 67 64 63 62 64 77 67 73 73 82 79 76 75 72 74 69 75 75 80.7 76 74.7 73 75.7 99 99 99 99 99 99 99 99 99 99 99 99 99 99 99 99 99 99 
17 64 62 56 55 58 56 49 57   67 52 49 52 54 56 57 58 76 73 70 71 73 70 65 70   77 69.7 66 67.3 68 71 74 75.3 99 99 99 99 99 99 99 99   99 99 99 99 99 99 99 99 
18 67 60 58 54 55 56 57 58   55 53 64 66 60 46 52 55 81 71 71 69 69 72 73 39   69 67.7 77 79.7 76.7 63.3 66.3 68.7 99 99 99 99 99 99 99 99   99 99 99 99 99 99 99 99 
19 66 62 56 58 2 60 66 70 64  54 56 48 47 54 52 56 54 85 78 73 73 35 73 76 80 76  73 72.7 66.3 64 71.7 71 73.3 72.7 99 99 99 99 99 99 99 99 99  99 99 99 99 99 99 99 99 
20 46 47 48 51 53 55 52 51 45 47 51 47 49 48 51 53 50 52 59 58 59 61 63 64 63 61 59 59 62 59 61.7 60.3 62.7 65.7 64.3 66.3 99 99 99 99 99 99 99 99 99 99 99 99 99 99 99 99 99 99 
21 46 48 51 53 54 55 57    54 57 53 58 63 62 55 54 67 67 67 70 71 72 71    68 69.3 67.7 69.3 75 72.7 68.7 67.3 99 99 99 99 99 99 99    99 99 99 99 99 99 99 99 
22 46 47 48 51 53 52 54    55 58 45 48 50 53 55 57 61 59 61 62 63 62 65    65 67 59.3 61 62 64.7 67.3 69 99 99 99 99 99 99 99    99 99 99 99 99 99 99 99 
23 55 56 58 61 62 67 58 62 66  55 61 66 67 49 48 51 53 77 73 74 75 75 79 75 79 83  73 74.7 79 80.3 65.3 66.3 69 72.7 99 99 99 99 99 99 99 99 99  99 99 99 99 99 99 99 99 
24 56 58 61 63 64 66 59 65   57 58 57 61 63 66 65 59 76 76 77 79 75 75 71 76   70 71 73 78 75.7 78.7 76.3 75 99 99 99 99 99 99 99 99   99 99 99 99 99 99 99 99 
25 66 67 63 59 58 56 57 52 54  56 68 64 62 60 54 58 56 86 83 78 73 72 69 69 69 72  72 81.3 77 76.3 75.3 72 76.7 73.7 99 99 99 99 99 99 99 99 99  99 99 99 99 99 99 99 99 
26 56 58 54 57 61 60 52 48   49 61 60 59 54 52 51 58 68 70 68 66 71 69 66 62   63 72 71.7 72 70 70 68.3 74 99 99 99 99 99 99 99 99   99 99 99 99 99 99 99 99 
27 56 52 48 49 52 55 55 53 56 59 56 54 55 58 61 63 65 63 73 72 66 65 65 67 68 67 71 75 71 70.7 70.3 70.7 73.3 75 77.7 76.7 99 99 99 99 99 99 99 99 99 99 99 99 99 99 99 99 99 99 
28 46 44 51 52 54 49 50 52   48 51 46 47 42 46 53 56 57 56 64 63 65 60 62 64   61 62.7 60 59.3 56.7 58.7 63 63.7 99 99 99 99 99 99 99 99   99 99 99 99 99 99 99 99 
29 56 58 59 61 63 62 59 58 63  55 62 60 57 54 52 53 52 69 68 70 70 71 72 71 70 74  68 73.3 72.7 70.3 69.3 69 70.3 70.3 99 99 99 99 99 99 99 99 99  99 99 99 99 99 99 99 99 
30 56 54 52 55 57 56 53 54   60 49 46 47 43 44 51 50 69 66 64 65 66 65 64 65   71 63.7 60.3 63 59 60.3 64.7 66 99 99 99 99 99 99 99 99   99 99 99 99 99 99 99 99 
 
 
 
 
 SL NO 
PAIN SCORE(FLACC) DURATION 
SEDATION SCORE PONV 
RTN OF 
URINE 
POSTOP OF 
0 2h 4h 6h 8h 10 12h 16h 20h 24h ANALGESIA 30 60 1.5h 2h 3h 4h 5h 6h 
1 0 0 1 2 3 4 
    
600 5 4 3 3 3 2 2 1 nil nil 
2 0 0 0 0 2 3 4 
   
700 5 4 4 3 2 2 2 1 nil nil 
3 0 0 0 2 2 4 
    
590 5 4 3 3 2 2 2 1 nil nil 
4 0 0 0 1 2 4 
    
610 5 4 3 3 2 2 2 1 nil nil 
5 0 0 0 2 2 3 4 
   
720 5 4 3 3 3 3 2 1 nil nil 
6 0 0 0 0 3 4 
    
590 5 4 3 3 2 2 3 1 nil nil 
7 0 0 0 0 2 3 4 
   
720 5 4 3 3 3 2 2 1 nil nil 
8 0 0 0 0 3 4 
    
610 5 4 3 3 3 3 3 1 nil nil 
9 0 0 0 0 2 3 4 
   
690 5 4 3 3 2 2 2 1 nil nil 
10 0 0 0 0 2 4 
    
610 5 4 3 3 3 3 3 1 nil nil 
11 0 0 0 1 2 4 
    
620 5 4 3 3 3 3 2 1 nil nil 
12 0 0 0 0 0 2 3 4 
  
900 5 4 4 3 2 2 2 1 nil nil 
13 0 0 0 0 2 3 4 
   
690 5 4 3 2 2 2 2 1 nil nil 
14 0 0 0 0 3 4 
    
630 5 4 3 3 3 3 2 1 nil nil 
15 0 0 0 1 3 4 
    
650 5 4 3 3 3 3 2 1 nil nil 
16 0 0 0 0 1 2 4 
   
700 5 4 3 2 2 2 2 1 nil nil 
17 0 0 0 2 3 4 
    
630 5 4 4 3 2 2 2 1 nil nil 
18 0 0 0 0 1 3 4 
   
710 5 4 3 2 2 2 2 1 nil nil 
19 0 0 0 0 2 3 4 
   
730 5 4 3 2 2 2 2 1 nil nil 
20 0 0 0 0 0 2 3 4 
  
850 5 4 3 2 2 2 1 1 nil nil 
21 0 0 0 1 2 4 
    
650 5 4 3 2 2 2 2 1 nil nil 
22 0 0 0 0 1 3 4 
   
720 5 4 3 2 2 2 3 1 nil nil 
23 0 0 0 0 1 3 4 
   
730 5 4 3 3 3 3 2 1 nil nil 
24 0 0 0 0 0 4 
    
620 5 4 4 3 2 2 2 1 nil nil 
25 0 0 0 0 1 2 4 
   
750 5 4 3 2 2 2 2 1 nil nil 
26 0 0 0 0 2 4 
    
620 5 4 3 3 3 3 3 1 nil nil 
27 0 0 0 0 2 3 4 
   
730 5 4 4 3 2 2 2 1 nil nil 
28 0 0 0 0 3 4 
    
630 5 4 3 3 3 3 2 1 nil nil 
29 0 0 0 0 1 3 4 
   
750 5 4 3 2 2 2 2 1 nil nil 
30 0 0 0 0 2 3 4 
   
720 5 4 4 4 3 2 2 1 nil nil 
                       

 
PROFORMA 
Date:     Roll no:    Group 
Name:    Age/Sex:    IP no: 
Wt:      
Diagnosis: 
Surgical Procedure done: 
Pre op assessment: 
History: 
Any H/O co-morbid illness 
Any H/O previous surgery 
O/E:     CVS:     RS: 
BP:     PR:     SPO2: 
ASA status: 
Drugs used: 
Induction:         Maintenance: 
Time of administration of caudal block: 
Duration of surgery: 
Intra OP events: 
Time Events HR BP SPO2 
     
     
     
     
 
Post OP events 
Time(Hrs) HR BP Pain Score Sedation Score 
     
     
     
     
 
 
Complication: 
Group Respiratory 
Depression 
Apnea Pruitis Urinary 
Retention 
Nausea & 
Vomiting 
      
 
                                                 DOSE               TIME 
Inj.ATROPINE 
Inj.EPHEDRINE 
PATIENT CONSENT FORM 
 
Study title        : “Effect of Dexmeditomidine with Bupivacaine for Caudal Block in 
Lower Abdominal Surgeries in Children “   
 
Study centre    :           Institute of Child health  &Hospital for children                                                                                                                 
                                       Madras medical college, Chennai. 
 
Participant name :                                Age:                         Sex:                                I.P.No: 
 
                  
I confirm that i have understood the purpose of procedure for the above study. i 
have the opportunity to ask the question and all my questions and doubts have been 
answered to my satisfaction. 
                      
I have been explained about the pitfall in the procedure.  I have been explained 
about the safety, advantage and disadvantage of the technique. 
 
I understand that my Child participation in the study is voluntary and that i am 
free to withdraw at anytime without giving any reason. 
 
I understand that investigator, regulatory authorities and the ethics committee 
will not need my permission to look at my Child health records both in respect to current 
study and any further research that may be conducted in relation to it, even if i 
withdraw from the study. I understand that my child identity will not be revealed in any 
information released to third parties or published, unless as required under the law. I 
agree not to restrict the use of any data or results that arise from the study. 
 
Time:          
 
Date:                                                                       signature / thumb impression of parent  
 
Place:                                                                      parent name: 
 
 
 
Signature of the investigator: 
 
Name of the investigator: 
 
 
